<SEC-DOCUMENT>0000917520-21-000029.txt : 20210518
<SEC-HEADER>0000917520-21-000029.hdr.sgml : 20210518
<ACCEPTANCE-DATETIME>20210518163236
ACCESSION NUMBER:		0000917520-21-000029
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210514
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210518
DATE AS OF CHANGE:		20210518

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRA LIFESCIENCES HOLDINGS CORP
		CENTRAL INDEX KEY:			0000917520
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				510317849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26224
		FILM NUMBER:		21936490

	BUSINESS ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		6092750500

	MAIL ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRA LIFESCIENCES CORP
		DATE OF NAME CHANGE:	19950614
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>iart-20210514.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:9d799a3e-0461-448d-85cf-baf8cc48f7a1,g:be4deb8a-a1ff-422e-be34-a925f2b6098d,d:1db69b8fadb446f58cd05b69978f0927--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>iart-20210514</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN180L2ZyYWc6ZWE3Mzg4YWVkY2YyNDJjZDkwMWE5ODJmYzk2ZjEzY2QvdGFibGU6OGFlNGU0ODVkMDg1NGUzMmIxOTYxOWNlYWE4NWU4NzMvdGFibGVyYW5nZTo4YWU0ZTQ4NWQwODU0ZTMyYjE5NjE5Y2VhYTg1ZTg3M18yLTEtMS0xLTA_0b454621-dbd0-4df4-80cc-cec592c40ffb">0000917520</ix:nonNumeric><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN180L2ZyYWc6ZWE3Mzg4YWVkY2YyNDJjZDkwMWE5ODJmYzk2ZjEzY2QvdGFibGU6OGFlNGU0ODVkMDg1NGUzMmIxOTYxOWNlYWE4NWU4NzMvdGFibGVyYW5nZTo4YWU0ZTQ4NWQwODU0ZTMyYjE5NjE5Y2VhYTg1ZTg3M181LTEtMS0xLTA_5e3c718c-c84f-44fa-88d3-1f0d864f5905">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="iart-20210514.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-14</xbrli:startDate><xbrli:endDate>2021-05-14</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i1db69b8fadb446f58cd05b69978f0927_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13.5pt;font-weight:400;line-height:120%">Washington, D.C. 20549 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQ2_806c3915-ca93-4bbb-8df5-4eb7f9a721ed">8-K</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 13 or 15(d) of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Securities Exchange Act of 1934 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8yMzM_8e9c1eb3-5684-49d9-b504-d4031e1ad5c0">May 14, 2021</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQx_3c941315-0729-4e25-8e4d-a83529f062d9">INTEGRA LIFESCIENCES HOLDINGS CORP</ix:nonNumeric>ORATION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter) </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.023%"><tr><td style="width:1.0%"></td><td style="width:40.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.686%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGFibGU6MzQ0YWMwOWU0MjkyNDE5NTkzMmJiODYyM2RjNTQ4NTkvdGFibGVyYW5nZTozNDRhYzA5ZTQyOTI0MTk1OTMyYmI4NjIzZGM1NDg1OV8wLTAtMS0xLTA_b08efcce-df34-4561-b87f-3e3c37b3d8ed">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGFibGU6MzQ0YWMwOWU0MjkyNDE5NTkzMmJiODYyM2RjNTQ4NTkvdGFibGVyYW5nZTozNDRhYzA5ZTQyOTI0MTk1OTMyYmI4NjIzZGM1NDg1OV8wLTEtMS0xLTA_8e61be86-ebc3-4427-b21b-51d4454d6a3a">0-26224</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGFibGU6MzQ0YWMwOWU0MjkyNDE5NTkzMmJiODYyM2RjNTQ4NTkvdGFibGVyYW5nZTozNDRhYzA5ZTQyOTI0MTk1OTMyYmI4NjIzZGM1NDg1OV8wLTItMS0xLTA_096aecec-35dc-4eda-b1be-fc62908ff2a0">51-0317849</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of  incorporation or organization) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQ3_b5421028-96b0-4e22-bcbc-914b274031fe">1100 Campus Road</ix:nonNumeric>  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQy_a7cb77a9-a5ca-48af-9da5-a87851b1e5f7">Princeton</ix:nonNumeric>, <ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzM1_58e3fff8-2d3c-44d6-a196-82c5aa0aaaa9">NJ</ix:nonNumeric> <ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzM2_52890413-6f7f-4130-a3b6-afc3168a9eb0">08540</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code: (<ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzM3_bbf16e99-969d-463c-bb27-aeed928134c0">609</ix:nonNumeric>) <ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzM4_15ae7b5d-ca07-4dd2-9b67-c70faf743046">275-0500</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report) </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzM5_de30d3ec-0d52-45b4-abaf-813d660609db">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQw_e80cc92c-a10c-4764-876b-ed00ed36b753">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQ0_4ee38095-8b17-42f1-b390-71188adaa7e7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR   240.14d-2(b))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQ1_857f681e-49bd-4700-80a9-8947ddffebdc">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities Registered Pursuant to Section12(b) of the Act:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.953%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.793%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.954%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGFibGU6MzEwMDA0YTFkMjgwNDhlOGI0NjJlYTM5ZGU4OTgwYzAvdGFibGVyYW5nZTozMTAwMDRhMWQyODA0OGU4YjQ2MmVhMzlkZTg5ODBjMF8xLTAtMS0xLTA_9b1e008e-d359-4e77-9443-2611343267e3">Common Stock, Par Value $.01 Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGFibGU6MzEwMDA0YTFkMjgwNDhlOGI0NjJlYTM5ZGU4OTgwYzAvdGFibGVyYW5nZTozMTAwMDRhMWQyODA0OGU4YjQ2MmVhMzlkZTg5ODBjMF8xLTEtMS0xLTA_8e9f9d85-9d2d-44ff-9bb1-faeab8d78e42">IART</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGFibGU6MzEwMDA0YTFkMjgwNDhlOGI0NjJlYTM5ZGU4OTgwYzAvdGFibGVyYW5nZTozMTAwMDRhMWQyODA0OGU4YjQ2MmVhMzlkZTg5ODBjMF8xLTItMS0xLTA_5a899074-f972-43bb-99d8-7e419b299b6a">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQz_67f429cf-3e6a-40cd-8995-3445b7248167">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i1db69b8fadb446f58cd05b69978f0927_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="margin-top:4.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Approval of the Fifth Amended and Restated 2003 Equity Incentive Plan </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;) held its 2021 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) on May 14, 2021.  At the Annual Meeting, the Company&#8217;s stockholders approved the Fifth Amended and Restated 2003 Equity Incentive Plan (the &#8220;Amended Plan&#8221;).  The Amended Plan was adopted by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) on April 1, 2021, subject to approval by the Company&#8217;s stockholders.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Plan amends and restates the Company&#8217;s Fourth Amended and Restated 2003 Equity Incentive Plan (the &#8220;2003 Plan&#8221;).  In particular, the Amended Plan makes the following material changes to the 2003 Plan:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Increases the maximum number of shares available by 1,900,000 shares to a total of 16,600,000 shares, and therefore increases the number of shares which may be granted as incentive stock options under the Amended Plan by 1,900,000 shares to 16,600,000 shares;</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Provides for a $750,000 limit on the total aggregate value of cash compensation and equity-based awards for any non-employee director for such director's service as a non-employee director during any fiscal year;</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Clarifies that the payment of dividends or dividend equivalents with respect to awards granted under the Amended Plan will only be paid out to the extent the applicable vesting conditions are satisfied and the shares underlying such awards are earned and vested; </span></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;Removes certain provisions from the Amended Plan that were otherwise required for awards to quality as performance-based compensation under Section 162(m) of the Internal Revenue Code of 1986, as amended, prior to its repeal under the Tax Cuts and Jobs Act of 2017; and </span></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;Extends the term of the Amended Plan through April 1, 2031.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms and conditions of the Amended Plan are described in the section entitled &#8220;Proposal 3 &#8211; Approval of the Fifth Amended and Restated 2003 Equity Incentive Plan&#8221; in the Company&#8217;s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 9, 2021.  The foregoing description of the Amended Plan does not purport to be complete and is qualified in its entirety by reference to the complete text of the Amended Plan, which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Committee Assignments </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2021, effective immediately, the Board appointed Shaundra Clay, a current member of the Board, as a member of the Audit Committee of the Board (the &#8220;Audit Committee&#8221;) and Keith Bradley, also a current member of the Board who served on the Audit Committee up until that date, to the Compensation Committee of the Board.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.07.  Submission of Matters to a Vote of Security Holders</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Annual Meeting of Stockholders of the Company was held on May 14, 2021.  The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item No. 1:  All of the Board of Directors&#8217; nominees for director were elected to serve until the Company&#8217;s 2022 Annual Meeting or until their respective successors are elected and qualified, by the votes set forth below.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Nominees</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Broker Non-Vote</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter J. Arduini</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,630,433&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701,833&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhonda G. Ballintyn</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,161,336&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,828&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,241&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Keith Bradley</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,837,191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,494,554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,660&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shaundra Clay</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,272,634&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,971&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,800&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stuart M. Essig</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,291,135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,041,531&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara B. Hill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,775,959&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,557,937&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,509&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald E. Morel, Jr.</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,210,801&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,246&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raymond G. Murphy</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,383,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948,605&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christian S. Schade</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,824,912&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506,841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,652&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349,866&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item No. 2:  The stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company&#8217;s independent registered public accounting firm for the 2021 fiscal year, by the votes set forth below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.487%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Broker Non-Vote</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,948,462</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,733,325</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,484</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item No. 3:  The stockholders approved the Amended Plan, by the votes set forth below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.487%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Broker Non-Vote</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,030,444</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273,155</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,806</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349,866</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item No. 4:  The stockholders approved, on an advisory, non-binding basis, the compensation of the Company&#8217;s named executive officers, by the votes set forth below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.487%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Broker Non-Vote</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,709,487</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606,770</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,148</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349,866</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.  Financial Statements and Exhibits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1  </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex101.htm">Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan </a></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104  Cover Page Interactive Data File (embedded within the inline XRBL document).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i1db69b8fadb446f58cd05b69978f0927_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.221%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:  May 18, 2021</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;/s/ Carrie Anderson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrie Anderson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:279pt;text-indent:-279pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Treasurer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i2e866d1746f842cf889c04532e58238a_38"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FIFTH AMENDED AND RESTATED 2003 EQUITY INCENTIVE PLAN </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(EFFECTIVE AS OF May&#160;14, 2021) </font></div><div style="margin-top:12pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;) desires to have the ability to award certain equity-based benefits to certain &#8220;Key Employees&#8221; and &#8220;Associates&#8221; (as defined below)&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW, THEREFORE, the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan is hereby adopted under the following terms and conditions. This Plan amends and restates in its entirety the Integra LifeSciences Holdings Corporation Fourth Amended and Restated 2003 Equity Incentive Plan, as amended (the &#8220;Prior Plan&#8221;). </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1)&#160;Purpose.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Plan is intended to provide a means whereby the Company may grant ISOs to Key Employees and may grant NQSOs, Restricted Stock, Stock Appreciation Rights, Performance Stock, Contract Stock, Dividend Equivalent Rights, Stock Payments and Other Incentive Awards to Key Employees and Associates. Thereby, the Company expects to attract and retain such Key Employees and Associates and to motivate them to exercise their best efforts on behalf of the Company and any Related Corporations and Affiliates. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2)&#160;Definitions </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Affiliate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall mean an entity in which the Company or a Related Corporation has a 50&#160;percent or greater equity interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Associate&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean a designated nonemployee director, consultant or other person providing services to the Company, a Related Corporation or an Affiliate. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Award&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean any award granted under the Plan to a Participant pursuant to any terms and conditions established by the Committee in the Award Agreement. Awards granted under the Plan my include&#58; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Stock Options, both Incentive (ISOs) and Non-qualified (NQSOs) per section 7.1&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Stock Appreciation Rights per section 7.2&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Restricted Stock per section 7.3&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Performance Stock per section 7.4&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Contract Stock per section 7.5&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;Dividend Equivalent Rights per section 7.6&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;Stock Payments per section 7.7 and&#47;or&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;Other Incentive Awards per section 7.8. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Award Agreement&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean the document issued, either in writing or an electronic medium, by the Committee to a participant evidencing the grant of an Award, as described in Section&#160;11.1. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Board&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean the Board of Directors of the Company. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to any Participant, &#8220;Cause&#8221; as defined in such Participant&#8217;s employment agreement or severance agreement with the Company if such an agreement exists and contains a definition of Cause or, if no such agreement exists or such agreement does not contain a definition of Cause, then Cause shall mean (i)&#160;the Participant&#8217;s neglect of duties or responsibilities that he or she is required to perform for the Company or any willful failure by the Participant to obey a lawful direction of the Board or the Company&#59; (ii)&#160;the Participant&#8217;s engaging in any act of dishonesty, fraud, embezzlement, misrepresentation or other act of moral turpitude&#59; (iii)&#160;the Participant&#8217;s knowing violation of any federal or state law or regulation applicable to the </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s business&#59; (iv)&#160;the Participant&#8217;s material breach of any confidentiality, non-compete agreement or invention assignment agreement or any other material agreement between the Participant and the Company&#59; (v)&#160;the Participant&#8217;s conviction of, or plea of nolo contendere to, any felony or crime of moral turpitude which conviction or plea is materially and demonstrably injurious to the Company or any of its subsidiaries&#59; (vi)&#160;failure by the Participant to comply with the Company&#8217;s material written policies or rules&#59; or (vii)&#160;the Participant&#8217;s act or omission in the course of his or her employment which constitutes gross negligence or willful misconduct. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Change in Control&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean&#58; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i)&#160;An acquisition (other than directly from the Company) of any voting securities of the Company (&#8220;Voting Securities&#8221;) by any &#8220;Person&#8221; (as such term is used for purposes of section&#160;13(d) or 14(d) of the Exchange Act) immediately after which such Person has &#8220;Beneficial Ownership&#8221; (within the meaning of Rule&#160;13d-3 promulgated under the Exchange Act) of 50&#160;percent or more of the combined voting power of all the then outstanding Voting Securities, other than the Company, any trustee or other fiduciary holding securities under any employee benefit plan of the Company or an affiliate thereof, or any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company&#59; provided, however, that any acquisition from the Company or any acquisition pursuant to a transaction which complies with paragraph (iii)(A) and (B)&#160;below shall not be a Change in Control under this paragraph (i)&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii)&#160;The individuals who, as of March&#160;1, 2003, are members of the Board (the &#8220;Incumbent Board&#8221;) cease for any reason to constitute at least two-thirds of the Board&#59; provided, however, that if the election, or nomination for election by the stockholders, of any new director was approved by a vote of at least two-thirds of the members of the Board who constitute Incumbent Board members, such new directors shall for all purposes be considered as members of the Incumbent Board as of March&#160;1, 2003, provided further, however, that no individual shall be considered a member of the Incumbent Board if such individual initially assumed office as a result of either an actual or threatened &#8220;Election Contest&#8221; (as described in Rule&#160;14a-11 promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board of Directors (a &#8220;Proxy Contest&#8221;) including by reason of any agreement intended to avoid or settle any Election Contest or Proxy Contest&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii)&#160;consummation by the Company of a reorganization, merger, or consolidation or sale or other disposition of all or substantially all of the assets of the Company or the acquisition of assets or stock of another entity (a &#8220;Business Combination&#8221;), unless immediately following such Business Combination&#58; (A)&#160;more than 50&#160;percent of the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors of (I)&#160;the corporation resulting from such Business Combination (the &#8220;Surviving Corporation&#8221;), or (II)&#160;if applicable, a corporation which as a result of such transaction owns the Company or all or substantially all of the Company&#8217;s assets either directly or through one or more subsidiaries (the &#8220;Parent Corporation&#8221;), is represented, directly or indirectly, by Company Voting Securities outstanding immediately prior to such Business Combination (or, if applicable, is represented by shares into which such Company Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportions as their ownership, immediately prior to such Business Combination, of the Company Voting Securities&#59; and (B)&#160;at least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) were members of the Incumbent Board at the time of the execution of the initial agreement, or the action of the Board, providing for such Business Combination&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv)&#160;approval by the stockholders of the Company of a complete liquidation or dissolution of the Company&#59;&#160;or </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v)&#160;acceptance by the stockholders of the Company of shares in a share exchange if the stockholders of the Company immediately before such share exchange do not own, directly or indirectly, immediately following such share exchange more than 50&#160;percent of the combined voting power of the outstanding Voting Securities of the corporation resulting from such share exchange in substantially the same proportion as their ownership of the Voting Securities outstanding immediately before such share exchange. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Code&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean the Internal Revenue Code of 1986, as amended. </font></div><div style="margin-top:4.5pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Committee&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean the Company&#8217;s Compensation Committee of the Board, which shall consist solely of not fewer than two directors of the Company who shall be appointed by, and serve at the pleasure of, the Board (taking into consideration the rules under section&#160;16(b) of the Exchange Act. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean Integra LifeSciences Holdings Corporation, a Delaware corporation. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Contract Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean the date specified in the Award Agreement on which a Participant is entitled to receive Contract Stock. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Stock&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean an Award that entitles the recipient to receive unrestricted Shares, without payment, as of a future date specified in the Award Agreement pursuant to section 7.5. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Disability&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean separation from service as a result of &#8220;permanent and total disability,&#8221; as defined in section 22(e)(3) of the Code. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Dividend Equivalent Right&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean an Award that a Participant could receive in lieu of a cash dividend that would have been payable on any or all Shares subject to another Award granted to the Participant had such Shares been outstanding. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Exchange Act&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean the Securities Exchange Act of 1934, as amended. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Exercise Price&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall mean the price of a Share, as fixed by the Committee, which may be purchased under an Option or with respect to which the amount of any payment pursuant to a Stock Appreciation Right is determined. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Fair Market Value&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean the following, arrived at by a good faith determination of the Committee&#58; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i)&#160;if there are sales of Shares on a national securities exchange or in an over-the-counter market on the date of grant (or on such other date as value must be determined), then the quoted closing price on such date&#59;&#160;or </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii)&#160;if there are no such sales of Shares on the date of grant (or on such other date as value must be determined), then the quoted closing price on the last preceding date for which such quotation exists&#59;&#160;or </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii) if the Shares are not listed on an established securities exchange or over-the-counter market system on the date of grant, but the Shares are regularly quoted by a recognized securities dealer, then the mean of the high bid and low asked prices for such date or, if there are no high bid and low asked prices for a Share on such date, the high bid and low asked prices for a Share on the last preceding date for which such information exists&#59;&#160;or </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv)&#160;if paragraphs (i)&#160;through (iii)&#160;above are not applicable, then such other method of determining fair market value as shall be adopted by the Committee. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to any Participant, &#8220;Good Reason&#8221; as defined in an employment, severance or applicable award agreement between such Participant and the Company if such an agreement exists and contains a definition of Good Reason or, if no such agreement exists or such agreement does not contain a definition of Good Reason, then Good Reason shall mean, without the express written consent of the Participant, the occurrence of any of the following&#58; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) a material diminution in the Participant&#8217;s authority, duties or responsibilities or the assignment of duties to the Participant that are materially inconsistent with the Participant&#8217;s position with the Company&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) a material reduction in the Participant&#8217;s base salary&#59; or </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) a change in the geographic location at which the Participant must perform services to a location more than fifty miles from the location at which the Participant normally performs such services as of the date of grant of the award, provided, that the Participant&#8217;s resignation shall only constitute a resignation for Good Reason if (x)&#160;the Participant provides the Company with a notice of termination for Good Reason within thirty days after the initial existence of the facts or circumstances constituting Good Reason, (y)&#160;the Company has failed to cure such facts or circumstances within thirty days after receipt of the notice of termination, and (z)&#160;the date of termination occurs no later than sixty days after the initial occurrence of the facts or circumstances constituting Good Reason. </font></div><div style="margin-top:4.5pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Incentive Stock Option (ISO)&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean an Option which, at the time such Option is granted under the Plan, qualifies as an incentive stock option within the meaning of section&#160;422 of the Code, unless the Award Agreement states that the Option will not be treated as an ISO pursuant to section 7.1. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Key Employee&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean an officer, executive, or managerial or non-managerial employee of the Company, a Related Corporation, or an Affiliate. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Non-qualified Stock Option (NQSO)&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean an Option that, at the time such Option is granted to a Participant, does not meet the definition of an ISO, whether or not it is designated as a nonqualified stock option in the Award Agreement pursuant to section 7.1. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Option&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is an Award entitling the Participant on exercise thereof to purchase Shares at a specified exercise price. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Incentive Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is an Award denominated in, linked to or derived from Shares or value metrics related to Shares, granted pursuant to Section&#160;7.8 hereof. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Participant&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean a Key Employee or Associate who has been granted an Award under the Plan. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Performance Stock&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean an Award that entitles the recipient to receive Shares, without payment, following the attainment of designated Performance Goals pursuant to section 7.4. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Performance Goals&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean goals deemed by the Committee to be important to the success of the Company or any of its Related Corporations or Affiliates. The Committee shall establish the specific measures for each such goal at the time an Award of Performance Stock is granted. In creating these measures, the Committee shall use one or more of the following business criteria with respect to (A)&#160;the Company, any of its Related Corporations or Affiliates, (B)&#160;the Company&#8217;s, a Related Corporation&#8217;s or an Affiliate&#8217;s worldwide operations, regional operations, country specific operations and&#47;or subsidiaries, business units, affiliates, corporations, divisions, groups, functions or employees and&#47;or (C)&#160;the Company&#8217;s, a Related Corporation&#8217;s or an Affiliate&#8217;s brands, groups of brands or specific brands&#58; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Asset turnover&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Capacity utilization&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Cash flow&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Cost improvements&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Costs or expenses&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;Customer retention&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;Customer satisfaction and&#47;or growth&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;Diversity&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;Earnings before interest, taxes, depreciation and amortization&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;Adjusted earnings before interest, taxes, depreciation and amortization&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;Earnings per share&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;Adjusted earnings per share&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;Economic value or economic value added&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;Employee satisfaction&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;Environmental health and safety&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;Financial and other capital-raising transactions&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.&#160;&#160;&#160;&#160;Free cash flow&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.&#160;&#160;&#160;&#160;Gross or net profit&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.&#160;&#160;&#160;&#160;Gross or net sales&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.&#160;&#160;&#160;&#160;Implementation or completion of critical projects&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.&#160;&#160;&#160;&#160;Increase in customer base&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.&#160;&#160;&#160;&#160;Inventory turnover&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.&#160;&#160;&#160;&#160;Market price appreciation of Shares&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.&#160;&#160;&#160;&#160;Market share&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.&#160;&#160;&#160;&#160;Mergers and acquisition integration&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.&#160;&#160;&#160;&#160;Net income margin&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.&#160;&#160;&#160;&#160;Net income or adjusted net income&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.&#160;&#160;&#160;&#160;Operating cash flow&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.&#160;&#160;&#160;&#160;Operating earnings&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.&#160;&#160;&#160;&#160;Operating profit margin&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.&#160;&#160;&#160;&#160;Operating profit&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.&#160;&#160;&#160;&#160;Pre-tax income&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.&#160;&#160;&#160;&#160;Price per Share&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.&#160;&#160;&#160;&#160;Profitability growth&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35.&#160;&#160;&#160;&#160;Profitability&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.&#160;&#160;&#160;&#160;Quality&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.&#160;&#160;&#160;&#160;Recruiting and maintaining personnel, </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.&#160;&#160;&#160;&#160;Regulatory body approval for commercialization of a product&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.&#160;&#160;&#160;&#160;Research and development achievements&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.&#160;&#160;&#160;&#160;Return on assets&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.&#160;&#160;&#160;&#160;Return on capital&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.&#160;&#160;&#160;&#160;Return on equity&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.&#160;&#160;&#160;&#160;Return on investment before or after the cost of capital&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.&#160;&#160;&#160;&#160;Return on net assets&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.&#160;&#160;&#160;&#160;Return on sales&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46.&#160;&#160;&#160;&#160;Revenue growth&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47.&#160;&#160;&#160;&#160;Revenue (including gross revenue or net revenue)&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48.&#160;&#160;&#160;&#160;Sales growth&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.&#160;&#160;&#160;&#160;Sales margin&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.&#160;&#160;&#160;&#160;Sales-related goals&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51.&#160;&#160;&#160;&#160;Stock price appreciation&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52.&#160;&#160;&#160;&#160;Total stockholder return&#59; </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53.&#160;&#160;&#160;&#160;Working capital&#59; and </font></div><div style="margin-top:6pt;padding-left:42.8pt;text-align:justify;text-indent:-18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.&#160;&#160;&#160;&#160;Year-end cash&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.5pt;text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business criteria may be expressed in absolute terms or as compared to any incremental increase or decrease or as compared to results of other companies or to market performance indicators or indices. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Plan&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as set forth herein and as it may be amended from time to time. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prior Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the Integra LifeSciences Holdings Corporation Fourth Amended and Restated 2003 Equity Incentive Plan, as amended by that certain amendment dated July&#160;16, 2020. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean a termination of a Participant&#8217;s service (i)&#160;by the Company without Cause or (ii)&#160;by the Participant for Good Reason as defined here or in an employment, severance, or applicable award agreement that contains a definition of Good Reason. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Related Corporation&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean either a &#8220;subsidiary corporation&#8221; of the Company (if any), as defined in section&#160;424(f) of the Code, or the &#8220;parent corporation&#8221; of the Company (if any), as defined in section&#160;424(e) of the Code. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Restatement Effective Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean the date on which this fifth amendment and restatement of the Plan was adopted by the Board. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Restricted Stock&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean an Award that grants the recipient Shares at no cost but subject to whatever restrictions are determined by the Committee pursuant to section 7.3. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Securities Act&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean the Securities Act of 1933, as amended. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Shares&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean shares of common stock of the Company. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Stock Appreciation Right&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall mean an Award entitling the recipient on exercise to receive an amount, in cash or Shares or a combination thereof (such form to be determined by the Committee), determined in whole or in part by reference to appreciation in Share value pursuant to section 7.2. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean a payment in the form of Shares awarded under Section&#160;7.7 hereof. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3.&#160;Administration </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;The Plan shall be administered by the Committee. Each member of the Committee, while serving as such, shall be deemed to be acting in his or her capacity as a director of the Company. Acts approved by a majority of the members of the Committee at which a quorum is present, or acts without a meeting reduced to or approved in writing by a majority of the members of the Committee, shall be the valid acts of the Committee. Any authority of the Committee may be delegated either by the Committee or the Board to a committee of the Board or any other Plan administrator, but only to the extent such delegation complies with the requirements of Rule&#160;16b-3 promulgated under the Exchange Act or as required by any other applicable rule or regulation. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;The Committee shall have the authority&#58; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i)&#160;to select the Key Employees and Associates to be granted Awards under the Plan and to grant such Awards at such time or times as it may choose&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii)&#160;to determine the type and size of each Award, including the number of Shares subject to the Award&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii)&#160;to determine the terms and conditions of each Award&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv)&#160;to amend an existing Award in whole or in part (including the extension of the exercise period for any NQSO), subject to the requirements set forth in subsection (c)&#160;below, and except that, without the consent of the Participant holding the Award, the Committee shall not take any action under this clause if such action would adversely affect the rights of such Participant&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v)&#160;to adopt, amend and rescind rules and regulations for the administration of the Plan&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi)&#160;to interpret the Plan and decide any questions and settle any controversies that may arise in connection with it&#59;&#160;and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.5pt;text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vii)&#160;to adopt such modifications, amendments, procedures, sub-plans and the like, which may be inconsistent with the provisions of the Plan, as may be necessary to comply with the laws and regulations of other countries in which the Company and its Related Corporations and Affiliates operate in order to assure the viability of Awards granted under the Plan to individuals in such other countries. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such determinations and actions of the Committee, and all other determinations and actions of the Committee made or taken under authority granted by any provision of the Plan, shall be conclusive and shall bind all parties. Nothing in this subsection&#160;(b) shall be construed as limiting the power of the Board or the Committee to make the adjustments described in Sections&#160;8.3 and 8.4. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Except as provided in Sections 8.3 or 8.4, the terms of outstanding Awards may not be amended to reduce the exercise price of outstanding Options or Stock Appreciation Rights or cancel outstanding Options or Stock Appreciation Rights in exchange for cash, other Awards or Options or Stock Appreciation Rights with an exercise price that is less than the exercise price of the original Options or Stock Appreciation Rights without stockholder approval. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4.&#160;Effective Date and Term of Plan </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Effective Date.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Plan shall be effective as of the Restatement Effective Date&#59; provided, however, that Section&#160;5, as amended and restated, will be subject to approval of the Plan by the Company&#8217;s stockholders. If the Plan is not approved by the Company&#8217;s stockholders within twelve (12)&#160;months after the Restatement Effective Date, then the Plan shall continue on its existing terms and conditions&#59; provided, however, that Section&#160;5 of the Prior Plan shall continue on its existing terms and conditions and Section&#160;5 of the Plan (as amended and restated) shall be of no force or effect. For purposes of this Section&#160;4(a), references to the Plan shall mean to the Fifth Amended and Restated Plan and not, for avoidance of doubt, to the Prior Plan. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Term of Plan.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No Awards may be granted or awarded during any period of suspension or after termination of the Plan, and in no event may any Award be granted under the Plan after the tenth (10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) anniversary of the date of its adoption (the &#8220;Expiration Date&#8221;). Any Awards that are outstanding on the Expiration Date, or the date of termination of the Plan (if earlier), shall remain in force according to the terms of the Plan and the applicable Award Agreement. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">5.&#160;Shares Subject to the Plan.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The aggregate number of Shares that may be delivered under the Plan is 16,600,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The maximum number of Shares which may be granted as ISOs is 16,600,000. Further, no Key Employee shall receive Awards for more than 2,000,000&#160;Shares in the aggregate during any calendar year under the Plan. However, the limits in the preceding sentences shall be subject to the adjustment described in Sections&#160;8.3 and 8.4. Shares delivered under the Plan may be authorized but unissued Shares, treasury Shares or reacquired Shares, and the Company may purchase Shares required for this purpose, from time to time, if it deems such purchase to be advisable. Any Shares still subject to an Option which expires or otherwise terminates for any reason whatsoever (including, without limitation, the surrender thereof) without having been exercised in full, any Shares that are still subject to an Award that is forfeited, any Shares withheld for the payment of taxes with respect to an Award, and the Shares subject to an Award which is payable in Shares or cash and that is satisfied in cash rather than in Shares shall continue to be available for Awards under the Plan. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">6.&#160;Eligibility.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The class of individuals who shall be eligible to receive Awards under the Plan shall be the Key Employees (including any directors of the Company who are also officers or Key Employees) and the Associates. More than one Award may be granted to a Key Employee or Associate under the Plan. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">7.&#160;Types of Awards </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Kinds of Options.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Both ISOs and NQSOs may be granted by the Committee under the Plan. However, ISOs may only be granted to Key Employees of the Company or of a Related Corporation. NQSOs may be granted to both Key Employees and Associates. Once an ISO has been granted, no action by the Committee that would cause the Option to lose its status as an ISO under the Code will be effective without the consent of the Participant holding the Option. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.5pt;text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;$100,000 Limit.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The aggregate Fair Market Value of the Shares with respect to which ISOs are exercisable for the first time by a Key Employee during any calendar year (counting ISOs under this Plan and under any other stock option plan of the Company or a Related Corporation) shall not exceed $100,000. If an Option intended as an ISO is granted to a Key Employee and the Option may not be treated in whole or in part as an ISO pursuant to the $100,000 limit, the Option shall be treated as an ISO to the extent it may be so treated under the limit and as an NQSO as to the remainder. For purposes of determining whether an ISO would cause the limit to be exceeded, ISOs shall be taken into account in the order granted. The annual limits set forth above for ISOs shall not apply to NQSOs. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Exercise Price.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The exercise price of an Option shall be determined by the Committee, subject to the following&#58; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i)&#160;The exercise price of an ISO shall not be less than the greater of (A)&#160;100&#160;percent (110&#160;percent in the case of an ISO granted to a Participant who owns more than 10&#160;percent of the total combined voting power of all classes of stock of the Company or any Subsidiary, as defined in Code Section&#160;424) of the Fair Market Value of the Shares subject to the Option, determined as of the time the Option is granted, or (B)&#160;the par value per Share. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii)&#160;The exercise price of an NQSO shall not be less than the greater of (A)&#160;100&#160;percent of the Fair Market Value of the Shares subject to the Option, determined as of the time the Option is granted, or (B)&#160;the par value per Share. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Term of Options.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The term of each Option may not be more than 10&#160;years (five years, in the case of an ISO granted to a Participant who owns more than 10&#160;percent of the total combined voting power of all classes of stock of the Company or any Subsidiary, as defined in Code Section&#160;424) from the date the Option was granted, or such earlier date as may be specified in the Award Agreement. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Exercise of Options.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;An Option shall become exercisable at such time or times (but not less than 1 year from the date of grant), and on such conditions, as the Committee may specify. The Committee may at any time and from time to time accelerate the time at which all or any part of the Option may be exercised. Any exercise of an Option must be in writing, signed by the proper person, and delivered or mailed to the Company or initiated and executed in any other form that is approved by the Company or a designated third-party administrator, accompanied by (i)&#160;any other documents required by the Committee and (ii)&#160;payment in full in accordance with subsection&#160;(f) below for the number of Shares for which the Option is exercised (except that, in the case of an exercise arrangement approved by the Committee and described in subsection (f)(iii) or subsection (f)(iv) below, payment may be made as soon as practicable after the exercise) or in any other format that is approved by the Company or a designated third-party administrator. Only full shares shall be issued under the Plan, and any fractional share that might otherwise be issuable upon exercise of an Option granted hereunder shall be forfeited. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Payment for Shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Shares purchased on the exercise of an Option shall be paid for as follows&#58; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i)&#160;in cash or by check (acceptable to the Committee), bank draft, or money order payable to the order of the Company&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii)&#160;in Shares previously acquired by the Participant&#59; provided, however, that if such Shares were acquired through the exercise of an NQSO and are used to pay the Option price of an ISO, or if such Shares were acquired through the exercise of an ISO or an NQSO and are used to pay the Option price of an NQSO, such Shares have been held by the Participant for such period of time, if any, as required to avoid negative accounting consequences&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii)&#160;by delivering a properly executed notice of exercise of the Option to the Company and a broker, with irrevocable instructions to the broker promptly to deliver to the Company the amount of sale or loan proceeds necessary to pay the exercise price of the Option&#59;&#160;or </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv) to the extent that the applicable Award Agreement so provides or the Committee otherwise determines, in Shares issuable pursuant to the exercise of an NQSO or otherwise withheld in a net settlement of an NQSO&#59; or </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v)&#160;by any combination of the above-listed forms of payment. </font></div><div style="margin-top:4.5pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the Option price is paid, in whole or in part, with Shares, the portion of the Option price so paid shall be equal to the Fair Market Value on the date of exercise of the Option of the Shares surrendered or withheld in payment of such Option price. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Grant of Stock Appreciation Rights.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Stock Appreciation Rights may be granted to a Key Employee or Associate by the Committee. Stock Appreciation Rights may be granted in tandem with, or independently of, Options granted under the Plan. A Stock Appreciation Right granted in tandem with an Option that is not an ISO may be granted either at or after the time the Option is granted. A Stock Appreciation Right granted in tandem with an ISO may be granted only at the time the ISO is granted. The exercise price of a Stock Appreciation Right shall not be less than the greater of (A)&#160;100&#160;percent of the Fair Market Value of the Shares subject to the Stock Appreciation Right, determined as of the time the Stock Appreciation Right is granted, or (B)&#160;the par value per Share. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Nature of Stock Appreciation Rights.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;A Stock Appreciation Right entitles the Participant to receive, with respect to each Share as to which the Stock Appreciation Right is exercised, the excess of the Share&#8217;s Fair Market Value on the date of exercise over its Fair Market Value on the date the Stock Appreciation Right was granted. Such excess shall be paid in cash, Shares, or a combination thereof, as determined by the Committee. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Rules&#160;Applicable to Tandem Awards.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;When Stock Appreciation Rights are granted in tandem with Options, the number of Stock Appreciation Rights granted to a Participant that shall be exercisable during a specified period shall not exceed the number of Shares that the Participant may purchase upon the exercise of the related Option during such period. Upon the exercise of an Option, the Stock Appreciation Right relating to the Shares covered by such Option will terminate. Upon the exercise of a Stock Appreciation Right, the related Option will terminate to the extent of an equal number of Shares. The Stock Appreciation Right will be exercisable only at such time or times, and to the extent, that the related Option is exercisable and will be exercisable in accordance with the procedure required for exercise of the related Option. The Stock Appreciation Right will be transferable only when the related Option is transferable, and under the same conditions. A Stock Appreciation Right granted in tandem with an ISO may be exercised only when the Fair Market Value of the Shares subject to the ISO exceeds the exercise price of such ISO. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Exercise of Independent Stock Appreciation Rights.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;A Stock Appreciation Right not granted in tandem with an Option shall become exercisable at such time or times, and on such conditions, as the Committee may specify in the Award Agreement. The Committee may at any time accelerate the time at which all or any part of the Stock Appreciation Right may be exercised. Any exercise of an independent Stock Appreciation Right must be in writing, signed by the proper person, and delivered or mailed to the Company, accompanied by any other documents required by the Committee. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Term of Stock Appreciation Rights.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The term of each Stock Appreciation Right may not be more than 10&#160;years from the date the Stock Appreciation Right was granted, or such earlier date as may be specified in the Award Agreement. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;General Requirements.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Restricted Stock may be issued or transferred to a Key Employee or Associate (for no cash consideration), to the extent permitted by applicable law. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Rights as a Stockholder.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Unless the Committee determines otherwise, a Key Employee or Associate who receives Restricted Stock shall have certain rights of a stockholder with respect to the Restricted Stock, including voting and dividend rights, subject to (i)&#160;the restrictions described in subsection (c)&#160;below, (ii) with respect to Awards granted on or after July&#160;16, 2020, Section&#160;7.6(ii) below, and (iii)&#160;any other conditions imposed by the Committee at the time of grant. Unless the Committee determines otherwise, certificates evidencing shares of Restricted Stock will remain in the possession of the Company until such Shares are free of all restrictions under the Plan. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Restrictions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Except as otherwise specifically provided by the Plan, Restricted Stock may not be sold, assigned, transferred, pledged, or otherwise encumbered or disposed of, and if the Participant ceases to provide services to any of the Company and its Related Corporations and Affiliates for any reason, must be forfeited to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company. These restrictions will lapse at such time or times, and on such conditions, as the Committee may specify in the Award Agreement (but no less than 1 year from the date of grant). Upon the lapse of all restrictions, the Shares will cease to be Restricted Stock for purposes of the Plan. The Committee may at any time accelerate the time at which the restrictions on all or any part of the Shares will lapse. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Notice of Tax Election.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Any Participant making an election under section&#160;83(b) of the Code for the immediate recognition of income attributable to an Award of Restricted Stock must provide a copy thereof to the Company within 10&#160;days of the filing of such election with the Internal Revenue Service. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Performance Stock&#59; Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Grant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Committee may grant Performance Stock to any Key Employee or Associate, conditioned upon the meeting of designated Performance Goals. The Committee shall determine the number of Shares of Performance Stock to be granted. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Performance Period and Performance Goals.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;When Performance Stock is granted, the Committee shall establish the performance period during which performance shall be measured, the Performance Goals, and such other conditions of the Award as the Committee deems appropriate. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Delivery of Performance Stock.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;At the end of each performance period, the Committee shall determine to what extent the Performance Goals and other conditions of the Award have been met and the number of Shares, if any, to be delivered with respect to the Award. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.&#160;Contract Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Grant.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Committee may grant Contract Stock to any Key Employee or Associate, conditioned upon the Participant&#8217;s continued provision of services to the Company and its Related Corporations and Affiliates through the vesting date(s) specified in the Award Agreement. The Committee shall determine the number of Shares of Contract Stock to be granted. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Contract Date.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;When Contract Stock is granted, the Committee shall establish the Contract Date on which the Contract Stock shall be delivered to the Participant. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Delivery of Contract Stock.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;To the extent that the Participant has satisfied the vesting conditions as of the Contract Date, the Committee shall cause the Contract Stock to be delivered to the Participant in accordance with the terms of the Award Agreement. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.6.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Equivalent Rights.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Committee may provide for payment to a Key Employee or Associate of Dividend Equivalent Rights, either currently or in the future, or for the investment of such Dividend Equivalent Rights on behalf of the Participant&#59; provided, however, that (i)&#160;Dividends or Dividend Equivalent Rights may not be granted to Participants in connection with grants of Options or Stock Appreciation Rights and (ii)&#160;except to the extent otherwise provided in Award Agreements entered into prior to April&#160;1, 2009, (a) any dividends payable with respect to an Award prior to vesting of such Award instead shall be paid out to the Participant only to the extent that the applicable vesting conditions are subsequently satisfied and the Award vests, and any dividends payable with respect to the portion of an Award that does not vest shall be forfeited, and (b)&#160;Dividend Equivalent Right payments with respect to an Award shall be paid out to the Participant only to the extent that the applicable vesting conditions are subsequently satisfied and the Award vests, and Dividend Equivalent Right payments with respect to the portion of an Award that does not vest shall be forfeited. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.7 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee is authorized to make one or more Stock Payments to any Key Employee or Associate. The number or value of Shares of any Stock Payment shall be determined by the Committee and may be based upon one or more Performance Goals or any other specific criteria, including service to the Company or any Related Corporation, determined by the Committee. Stock Payments may, but are not required to be made in lieu of base salary, bonus, fees or other cash compensation otherwise payable to such Key Employee or Associate. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.8 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Incentive Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee is authorized to grant Other Incentive Awards to any Key Employee or Associate, which Awards may cover Shares or the right to purchase or receive Shares or have a value derived from the value of, or an exercise or conversion privilege at a price related to, or that are otherwise payable in or based on, Shares, shareholder value or shareholder return, in each case, on a specified date or dates or over any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period or periods determined by the Committee. Other Incentive Awards may be linked to any one or more of the Performance Goals or other specific performance criteria determined appropriate by the Committee. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.9 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With respect to Awards granted on or after July&#160;16, 2020, (i) notwithstanding any other provision of the Plan to the contrary, all Awards, and all portions of Awards, shall be subject to a minimum vesting schedule of at least twelve (12)&#160;months following the date of grant of the Award&#59; provided that the foregoing limitations shall not preclude the acceleration of vesting of any such Award upon the death or Disability of a Participant or preclude the double-trigger Change in Control treatment set forth in Section&#160;8.5(a) of the Plan. Notwithstanding the foregoing, Awards granted on or after July&#160;16, 2020 with respect to 5% of the Share Limit may be granted under the Plan to any one or more Participants without respect to such minimum vesting provisions. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">8.&#160;Events Affecting Outstanding Awards </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Termination of Service (Other Than by Death or Disability).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;If a Participant ceases to provide services to the Company and its Related Corporations and Affiliates for any reason other than death or Disability, as the case may be, the following shall apply&#58; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;Except as otherwise determined by the Committee, all Options and Stock Appreciation Rights held by the Participant that were not exercisable immediately prior to the Participant&#8217;s termination of service shall terminate at that time. Any Options or Stock Appreciation Rights that were exercisable immediately prior to the termination of service will continue to be exercisable for six months (or for such longer period as the Committee may determine), and shall thereupon terminate, unless the Award Agreement provides by its terms for immediate termination or for termination in less than six months in the event of termination of service. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In no event, however, shall an Option or Stock Appreciation Right remain exercisable beyond the latest date on which it could have been exercised without regard to this Section. For purposes of this subsection (a), a termination of service shall not be deemed to have resulted by reason of a sick leave or other bona fide leave of absence approved for purposes of the Plan by the Committee. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;Except as otherwise determined by the Committee, all Restricted Stock held by the Participant at the time of the termination of service must be transferred to the Company (and, in the event the certificates representing such Restricted Stock are held by the Company, such Restricted Stock shall be so transferred without any further action by the Participant), in accordance with Section&#160;7.3. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;Except as otherwise determined by the Committee, all Performance Stock, Other Incentive Awards, Contract Stock, and Dividend Equivalent Rights to which the Participant was not irrevocably entitled prior to the termination of service shall be forfeited and the Awards canceled as of the date of such termination of service. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Death or Disability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;If a Participant dies or incurs a Disability, the following shall apply&#58; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;Except as otherwise determined by the Committee, all Options and Stock Appreciation Rights held by the Participant immediately prior to death or Disability, as the case may be, to the extent then exercisable, may be exercised by the Participant or by the Participant&#8217;s legal representative (in the case of Disability), or by the Participant&#8217;s executor or administrator or by the person or persons to whom the Option or Stock Appreciation Right is transferred by will or the laws of descent and distribution, at any time within the one-year period ending with the first anniversary of the Participant&#8217;s death or Disability (or such shorter or longer period as the Committee may determine), and shall thereupon terminate. In no event, however, shall an Option or Stock Appreciation Right remain exercisable beyond the latest date on which it could have been exercised without regard to this Section. Notwithstanding the foregoing, except as otherwise determined by the Committee, in the event of a Participant&#8217;s death or Disability, all outstanding Options and Stock Appreciation Rights held by a Participant (other than Participants in France) immediately prior to such death or Disability shall vest and become exercisable in full. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;Except as otherwise determined by the Committee, all Restricted Stock held by the Participant at the date of death or Disability, as the case may be, must be transferred to the Company (and, in the event the certificates </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">representing such Restricted Stock are held by the Company, such Restricted Stock shall be so transferred without any further action by the Participant), in accordance with Section&#160;7.3. Notwithstanding the foregoing, except as otherwise determined by the Committee, in the event of a Participant&#8217;s death or Disability, all restrictions on such Participant&#8217;s Restricted Stock granted on or after May&#160;17, 2012 (other than Restricted Stock granted to Participants in France) shall lapse and such Restricted Stock shall become vested Shares. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;Except as otherwise determined by the Committee, all Performance Stock, Other Incentive Awards, Contract Stock, and Dividend Equivalent Rights to which the Participant was not irrevocably entitled prior to death or Disability, as the case may be, shall be forfeited and the Awards canceled as of the date of death or Disability. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Capital Adjustments.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The maximum number of Shares that may be delivered under the Plan, and the maximum number of Shares with respect to which Awards may be granted to any Key Employee or Associate under the Plan, both as stated in Section&#160;5, and the number of Shares issuable upon the exercise or vesting of outstanding Awards under the Plan (as well as the exercise price per Share under outstanding Options or Stock Appreciation Rights), shall be proportionately adjusted, as may be deemed appropriate by the Committee, to reflect any increase or decrease in the number of issued Shares resulting from a subdivision (share-split), consolidation (reverse split), stock dividend, or similar change in the capitalization of the Company. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Certain Corporate Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;In the event of a corporate transaction (as, for example, a merger, consolidation, acquisition of property or stock, separation, reorganization, or liquidation), each outstanding Award shall be assumed by the surviving or successor entity&#59; provided, however, that in the event of a proposed corporate transaction, the Committee may terminate all or a portion of any outstanding Award, effective upon the closing of the corporate transaction, if it determines that such termination is in the best interests of the Company. If the Committee decides to terminate outstanding Options or Stock Appreciation Rights, the Committee shall give each Participant holding an Option or Stock Appreciation Right to be terminated not less than seven days&#8217; notice prior to any such termination, and any Option or Stock Appreciation Right that is to be so terminated may be exercised (if and only to the extent that it is then exercisable) up to, and including the date immediately preceding such termination. Further, subject to Section&#160;8.6 below, the Committee, in its discretion, may (i)&#160;accelerate, in whole or in part, the date on which any or all Options and Stock Appreciation Rights become exercisable, (ii)&#160;remove the restrictions from outstanding Restricted Stock, (iii)&#160;cause the delivery of any Performance Stock, even if the associated Performance Goals have not been met, (iv)&#160;cause the delivery of any Contract Stock, even if the Contract Date has not been reached, and&#47;or Other Incentive Awards&#59; and&#47;or (v)&#160;cause the payment of any Dividend Equivalent Rights. The Committee also may, in its discretion, change the terms of any outstanding Award to reflect any such corporate transaction, provided that, in the case of ISOs, such change would not constitute a &#8220;modification&#8221; under section&#160;424(h) of the Code, unless the Participant consents to the change. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;With respect to an outstanding Award held by a Participant who, following the corporate transaction, will be employed by or otherwise providing services to an entity which is a surviving or acquiring entity in such transaction or an affiliate of such an entity, the Committee may, in lieu of the action described in subsection&#160;(a) above, arrange to have such surviving or acquiring entity or affiliate grant to the Participant a replacement award which, in the judgment of the Committee, is substantially equivalent to the Award. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.&#160;Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of this Plan and subject to Section&#160;8.6 below&#58; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) To the extent allowed under applicable law or regulatory filings or unless otherwise determined by the Committee, in the event that a Change in Control occurs and the Participant incurs a Qualifying Termination on or within twelve (12)&#160;months following the date of such Change in Control, each outstanding Award held by a Participant, other than any Award subject to performance-vesting, shall become fully vested (and, as applicable, exercisable) and all forfeiture restrictions thereon shall lapse upon such Qualifying Termination. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Notwithstanding the foregoing, if a Change in Control constitutes a payment event with respect to any Award which provides for the deferral of compensation and is subject to section 409A of the Code, the Change in Control with respect to such Award must also constitute a &#8220;change in control event,&#8221; as defined in Treasury Regulation &#167; 1.409A-3(i)(5) to the extent required by section 409A. </font></div><div style="margin-top:4.5pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Section&#160;409A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No action shall be taken under this Section&#160;8 which shall cause an Award to fail to comply with section 409A of the Code or the Treasury Regulations thereunder, to the extent applicable to such Award. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">9.&#160;Amendment or Termination of the Plan </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;In General.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Board, pursuant to a written resolution, may from time to time suspend or terminate the Plan or amend it and, except as provided in Section&#160;3(b)(iv), 7.1(a), and 8.4(a), the Committee may amend any outstanding Awards in any respect whatsoever&#59; except that, without the approval of the stockholders (given in the manner set forth in subsection&#160;(b) below) no amendment may be made that would&#58; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i)&#160;change the class of employees eligible to participate in the Plan with respect to ISOs&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii)&#160;except as permitted under Section&#160;8.3, increase the maximum number of Shares with respect to which ISOs may be granted under the Plan&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii)&#160;increase the limits imposed in Section&#160;5 on the maximum number of Shares which may be issued or transferred under the Plan or increase the individual Key Employee award limit set forth in Section&#160;5&#59; </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv)&#160;extend the duration of the Plan under Section&#160;4(b) with respect to any ISOs granted hereunder&#59;&#160;or </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v)&#160;reprice or regrant through cancellation, or modify (except in connection with a change in the Company&#8217;s capitalization) any Award, if the effect would be to reduce the exercise price for the shares underlying such Award&#59; provided, however, with the approval of the Company&#8217;s stockholders, the Committee may (i)&#160;reduce the exercise price per share of any outstanding Option or Stock Appreciation Right granted under the Plan, or (ii)&#160;cancel any Option or Stock Appreciation Right in exchange for cash or another Award when the Option or Stock Appreciation Right exercise price per share exceeds the Fair Market Value of the underlying Shares. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, no such suspension, termination or amendment shall materially impair the rights of any Participant holding an outstanding Award without the consent of such Participant. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Manner of Stockholder Approval.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The approval of stockholders must be effected by a majority of the votes cast (including abstentions, to the extent abstentions are counted as voting under applicable state law) in a separate vote at a duly held stockholders&#8217; meeting at which a quorum representing a majority of all outstanding voting stock is, either in person or by proxy, present and voting on the Plan. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">10.&#160;Non-Employee Director Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any provision to the contrary in the Plan, the Committee or the Board may establish compensation for non-employee members of our Board from time to time, subject to the limitations in the Plan.&#160;The Committee or the Board will from time to time determine the terms, conditions and amounts of all such compensation for our non-employee members of our Board in its discretion and pursuant to the exercise of its business judgment, taking into account such factors, circumstances and considerations as it shall deem relevant from time to time&#59; provided that, the sum of any cash compensation, or other compensation, and the value (determined as of the grant date in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, or any successor thereto) of Awards granted to a non-employee member of the Board as compensation for services as a non-employee member of the Board Director during any fiscal year of the Company may not exceed $750,000 (which limits shall not apply to the compensation for any non-employee member of the Board who serves in any capacity in addition to that of a non-employee member of the Board for which he or she receives additional compensation). </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">11. Miscellaneous </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Documentation of Awards.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Awards shall be evidenced by such written Award Agreements, if any, as may be prescribed by the Committee from time to time. Such instruments may be in the form of agreements to be executed by both the Participant and the Company, or certificates, letters, or similar instruments, which need not be executed by the Participant but acceptance of which will evidence agreement to the terms thereof. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Rights as a Stockholder.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Except as specifically provided by the Plan or an Award Agreement, the receipt of an Award shall not give a Participant rights as a stockholder&#59; instead, the Participant shall obtain such rights, subject to any limitations imposed by the Plan or the Award Agreement, upon the actual receipt of Shares. </font></div><div style="margin-top:4.5pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Conditions on Delivery of Shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company shall not deliver any Shares pursuant to the Plan or remove restrictions from Shares previously delivered under the Plan (i)&#160;until all conditions of the Award have been satisfied or removed, (ii)&#160;until all applicable Federal and state laws and regulations have been complied with, and (iii)&#160;if the outstanding Shares are at the time of such delivery listed on any stock exchange, until the Shares to be delivered have been listed or authorized to be listed on such exchange. If an Award is exercised by the Participant&#8217;s legal representative, the Company will be under no obligation to deliver Shares pursuant to such exercise until the Company is satisfied as to the authority of such representative. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Registration and Listing of Shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;If the Company shall deem it necessary to register under the Securities Act or any other applicable statute any Shares purchased under this Plan, or to qualify any such Shares for an exemption from any such statutes, the Company shall take such action at its own expense. If Shares are listed on any national securities exchange at the time any Shares are purchased hereunder, the Company shall make prompt application for the listing on such national securities exchange of such Shares, at its own expense. Purchases and grants of Shares hereunder shall be postponed as necessary pending any such action. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Compliance with Rule&#160;16b-3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;All elections and transactions under this Plan by persons subject to Rule&#160;16b-3, promulgated under section&#160;16(b) of the Exchange Act, or any successor to such Rule, are intended to comply with at least one of the exemptive conditions under such Rule. The Committee shall establish such administrative guidelines to facilitate compliance with at least one such exemptive condition under Rule&#160;16b-3 as the Committee may deem necessary or appropriate. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Obligation to Withhold.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Company shall withhold from any cash payment made pursuant to an Award an amount sufficient to satisfy all Federal, state, and local withholding tax requirements (the &#8220;Withholding Requirements&#8221;). In the case of an Award pursuant to which Shares may be delivered, the Committee may require that the Participant or other appropriate person remit to the Company an amount sufficient to satisfy the Withholding Requirements, or make other arrangements satisfactory to the Committee with regard to the Withholding Requirements, prior to the delivery of any Shares. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Election to Withhold Shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Committee, in its discretion, may permit or require the Participant to satisfy the federal, state, and&#47;or local withholding tax, in whole or in part, by having the Company withhold Shares otherwise issuable under an Award (or by surrendering Shares to the Company)&#59; provided, however, that the number of Shares withheld shall have a Fair Market Value on the date of withholding no greater than the aggregate amount of such liabilities based on the maximum individual statutory Withholding Requirements for the applicable jurisdiction. In addition, the Committee, in its discretion, may permit or require the acceleration of the timing for the payment of the number of Shares needed to pay employment taxes upon the date of the vesting of an Award&#59; provided, however, that the Company may limit the number of Shares used for this purpose to the extent necessary to avoid adverse accounting consequences. Shares shall be valued, for purposes of this subsection (b), at their fair market value (determined as of the date an amount is includible in income by the Participant (the &#8220;Determination Date&#8221;), rather than the date of grant). Notwithstanding the foregoing, in no event shall any Participant be permitted to elect such accelerated payment to the extent that it would result in a violation of Treasury Regulation &#167; 1.409A-3(j) (including, without limitation, Treasury Regulation &#167; 1.409A-3(j)(4)(i)). The Committee shall adopt such withholding rules as it deems necessary to carry out the provisions of this Section. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Transferability of Awards.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No ISO may be transferred other than by will or by the laws of descent and distribution. No other Award may be transferred, except to the extent permitted in the applicable Award Agreement. During a Participant&#8217;s lifetime, an Award requiring exercise may be exercised only by the Participant (or, in the event of the Participant&#8217;s incapacity, by the person or persons legally appointed to act on the Participant&#8217;s behalf). Notwithstanding the foregoing, any transfer of an Award otherwise permitted by this Section&#160;11.7 shall be made only to a &#8220;family member&#8221; of the Participant within the meaning of the instructions to Form S-8 Registration Statement under the Securities Act (a &#8220;Permitted Transferee&#8221;). Notwithstanding the foregoing, in no event may an Award be transferable for consideration absent stockholder approval. Notwithstanding the foregoing, the Committee, in its sole discretion, may determine to permit a Participant or a Permitted Transferee of such Participant to transfer an Award other than an ISO (unless such ISO is to become a Non-Qualified Stock Option) to any one or more Permitted Transferees of such Participant, subject to the following terms and conditions&#58; (a)&#160;an Award transferred to a Permitted Transferee shall not be assignable or transferable by the Permitted Transferee (other than </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to another Permitted Transferee of the applicable Participant) other than by will or the laws of descent and distribution&#59; (b)&#160;an Award transferred to a Permitted Transferee shall continue to be subject to all the terms and conditions of the Award as applicable to the original Participant (other than the ability to further transfer the Award)&#59; and (c)&#160;the Participant (or transferring Permitted Transferee) and the Permitted Transferee shall execute any and all documents requested by the Committee, including without limitation, documents to (i)&#160;confirm the status of the transferee as a Permitted Transferee, (ii)&#160;satisfy any requirements for an exemption for the transfer under applicable federal, state and foreign securities laws and (iii)&#160;evidence the transfer. In addition, and further notwithstanding the foregoing hereof, the Committee, in its sole discretion, may determine to permit a Participant to transfer ISOs to a trust that constitutes a Permitted Transferee if, under Section&#160;671 of the Code and applicable state law, the Participant is considered the sole beneficial owner of the ISO while it is held in the trust. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Registration.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;If the Participant is married at the time Shares are delivered and if the Participant so requests at such time, the certificate or certificates for such Shares shall be registered in the name of the Participant and the Participant&#8217;s spouse, jointly, with right of survivorship. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Acquisitions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any other provision of this Plan, Awards may be granted hereunder (without reducing the Share Limit) in substitution for awards held by directors, key employees, and associates of other corporations who are about to, or have, become Key Employees or Associates as a result of a merger, consolidation, acquisition of assets, or similar transaction by the Company or a Related Corporation or (in the case of Awards other than ISOs) an Affiliate. The terms of the substitute Awards so granted may vary from the terms set forth in this Plan to such extent as the Committee may deem appropriate to conform, in whole or in part, to the provisions of the awards in substitution for which they are granted. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Employment Rights.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Neither the adoption of the Plan nor the grant of Awards will confer upon any person any right to continued employment by the Company or any of its Related Corporations or Affiliates or affect in any way the right of any of the foregoing to terminate an employment relationship at any time. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Indemnification of Board and Committee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Without limiting any other rights of indemnification that they may have from the Company or any of its Related Corporations or Affiliates, the members of the Board and the members of the Committee shall be indemnified by the Company against all costs and expenses reasonably incurred by them in connection with any claim, action, suit or proceeding to which they or any of them may be a party by reason of any action taken or failure to act under, or in connection with, the Plan or any Award granted thereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by legal counsel selected by the Company) or paid by them in satisfaction of a judgment in any such action, suit or proceeding, except a judgment based upon a finding of willful misconduct or recklessness on their part. Upon the making or institution of any such claim, action, suit or proceeding, the Board or Committee member shall notify the Company in writing, giving the Company an opportunity, at its own expense, to handle and defend the same before such Board or Committee member undertakes to handle it on his or her own behalf. The provisions of this Section shall not give members of the Board or the Committee greater rights than they would have under the Company&#8217;s by-laws or Delaware law. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Application of Funds.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Any cash proceeds received by the Company from the sale of Shares pursuant to Awards granted under the Plan shall be added to the general funds of the Company. Any Shares received in payment for additional Shares upon exercise of an Option shall become treasury stock. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;Governing Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The Plan shall be governed by the applicable Code provisions to the maximum extent possible. Otherwise, the laws of the State of Delaware (without reference to the principles of conflict of laws) shall govern the operation of, and the rights of Participants under, the Plan and Awards granted hereunder. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.14. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clawback, Repayment or Recapture Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding anything contained in the Plan to the contrary, to the extent allowed under applicable law or regulatory filings or unless otherwise determined by the Committee, all Awards granted under the Plan on or after January&#160;1, 2013, and any related payments made under the Plan after such date, shall be subject to the provisions of any clawback, repayment or recapture policy implemented by the Company, including any such policy adopted to comply with applicable law (including without limitation the Dodd-Frank Wall Street Reform and Consumer Protection Act) or securities exchange listing standards and any rules or regulations promulgated thereunder, to the extent set forth in such policy and&#47;or in any notice or agreement relating to an Award or payment under the Plan. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>iart-20210514.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9d799a3e-0461-448d-85cf-baf8cc48f7a1,g:be4deb8a-a1ff-422e-be34-a925f2b6098d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iart="http://integralife.com/20210514" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://integralife.com/20210514">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20210514_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20210514_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20210514_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://integralife.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>iart-20210514_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9d799a3e-0461-448d-85cf-baf8cc48f7a1,g:be4deb8a-a1ff-422e-be34-a925f2b6098d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://integralife.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="iart-20210514.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DocumentandEntityInformation" xlink:type="extended" id="i108d95fc9d7f4285945f8cab82367361_DocumentandEntityInformation">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_171c4d97-cdcb-4768-adc1-2309f27f0ac6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_DocumentType_171c4d97-cdcb-4768-adc1-2309f27f0ac6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_972aac6e-09f4-4e22-97fb-8cdfc46c2929" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_DocumentPeriodEndDate_972aac6e-09f4-4e22-97fb-8cdfc46c2929" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9f9e4be7-6c46-4323-8a3a-6e135fba208a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityRegistrantName_9f9e4be7-6c46-4323-8a3a-6e135fba208a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_91dbdc3c-44d1-4aeb-8c1d-0853046cedfe" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityIncorporationStateCountryCode_91dbdc3c-44d1-4aeb-8c1d-0853046cedfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_6d989612-dcb5-4733-980f-c481e1740922" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityFileNumber_6d989612-dcb5-4733-980f-c481e1740922" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6de35d49-12f9-414e-8c6c-0ac4d95338a4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityTaxIdentificationNumber_6de35d49-12f9-414e-8c6c-0ac4d95338a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_8824e021-ef17-4ad9-8ada-40ce4c6236c1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityAddressAddressLine1_8824e021-ef17-4ad9-8ada-40ce4c6236c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b5a7a6ab-5496-4d06-b1d2-4e008f5a6db5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityAddressCityOrTown_b5a7a6ab-5496-4d06-b1d2-4e008f5a6db5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b3906ffc-6698-4bd3-a70e-af8a176d9b8a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityAddressStateOrProvince_b3906ffc-6698-4bd3-a70e-af8a176d9b8a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_edbbc2ee-fffc-41e4-b0e1-11fcb464b696" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityAddressPostalZipCode_edbbc2ee-fffc-41e4-b0e1-11fcb464b696" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_83c298fa-e320-47b5-ad2d-2729abc66fc8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_CityAreaCode_83c298fa-e320-47b5-ad2d-2729abc66fc8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_78d98eb5-ceba-4c51-9283-a383115b34d3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_LocalPhoneNumber_78d98eb5-ceba-4c51-9283-a383115b34d3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9e5b1855-efff-47c0-b1ae-b56a8bcdefe7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_WrittenCommunications_9e5b1855-efff-47c0-b1ae-b56a8bcdefe7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_fcb0c9d1-8a9d-4d40-b6d0-640f5cfc7d30" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_SolicitingMaterial_fcb0c9d1-8a9d-4d40-b6d0-640f5cfc7d30" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_e5db3748-8d0b-4cd3-a617-fd6c0fc409ff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_PreCommencementTenderOffer_e5db3748-8d0b-4cd3-a617-fd6c0fc409ff" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_22660c61-83a4-4d51-9406-e93c214d25be" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_22660c61-83a4-4d51-9406-e93c214d25be" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_89b4780a-904d-4358-a17b-92e823456b77" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_Security12bTitle_89b4780a-904d-4358-a17b-92e823456b77" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_dc8d126d-aeaf-44fe-980c-ec345b74e64e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_TradingSymbol_dc8d126d-aeaf-44fe-980c-ec345b74e64e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_219d8934-ff20-4cb7-b973-5a5a95a04aeb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_SecurityExchangeName_219d8934-ff20-4cb7-b973-5a5a95a04aeb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_7f49f211-703d-47b8-91f0-2db522c2cf3b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityEmergingGrowthCompany_7f49f211-703d-47b8-91f0-2db522c2cf3b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4d1ec366-9585-4725-a253-0e80a5650078" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityCentralIndexKey_4d1ec366-9585-4725-a253-0e80a5650078" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0e2b9acb-6fcd-447b-a665-f6707f6f925a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_AmendmentFlag_0e2b9acb-6fcd-447b-a665-f6707f6f925a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_59016371-826b-4f86-9297-5f6a7821ca94" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntitiesTable_59016371-826b-4f86-9297-5f6a7821ca94" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_cb13f09f-0494-4ffc-b84a-5ac8e8e00e65" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_59016371-826b-4f86-9297-5f6a7821ca94" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_cb13f09f-0494-4ffc-b84a-5ac8e8e00e65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_cb13f09f-0494-4ffc-b84a-5ac8e8e00e65_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_cb13f09f-0494-4ffc-b84a-5ac8e8e00e65" xlink:to="loc_dei_AddressTypeDomain_cb13f09f-0494-4ffc-b84a-5ac8e8e00e65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_b5edde8b-a8cb-4c37-b172-1555acc2fabf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_cb13f09f-0494-4ffc-b84a-5ac8e8e00e65" xlink:to="loc_dei_AddressTypeDomain_b5edde8b-a8cb-4c37-b172-1555acc2fabf" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>iart-20210514_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9d799a3e-0461-448d-85cf-baf8cc48f7a1,g:be4deb8a-a1ff-422e-be34-a925f2b6098d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_56c68db4-178a-48a7-b9de-c3180d2777a2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_79b04d6a-52e7-4258-a896-f97f8b0c3b0a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_9268c89c-6ae2-4247-a243-86bdc6bf8f2e_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_c173cdd2-8ca1-435e-8d72-22f1c594c274_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_6e12b785-80e7-4343-a264-4d263adec6c2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_52229f42-2be2-4373-9e31-695785024eb0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a186c3c1-7f79-4880-a768-90ef911d430e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_75e48882-5b94-4fb8-8b6b-7e2c4a74a5c0_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_3ac77576-3f78-4a7e-b74c-0d3e9cf0a1a9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c08281aa-137e-4a5a-b6c9-96f5a875dc96_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_0f0f3e9d-c5c2-4c7f-ad28-73c2f346e2d4_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_0539f0b4-9a63-45b0-af39-927dc72cce14_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_566b9d58-4cc2-49b5-81cf-4ba03aef96e2_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ad7d6f84-2ccd-4811-9de3-6ae0938a7f2a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f680cbfe-a1f3-46ca-b809-8c0c63072461_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_bd47b9ed-0869-4c5f-8fa7-a80210bbd92a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_d8f44dfe-c5f3-405f-a2c4-93d69ac8a473_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_4d623ee8-e2f4-406f-8324-d316eb1111df_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_51c4df23-43bb-4b5a-861b-cf0965f333f9_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_adc5798b-8f0b-4e60-a6c1-ab2c3d972b00_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a131b999-3bd7-44b9-b4b3-e860c8d22c6e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_80190843-006b-4643-8a57-9bcc0f2ff1f1_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_b9c14cdd-5cc7-4450-9855-a4adee08172f_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_afb9cb6d-4347-4a15-9dc3-d1137370b77f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7050fcd3-a416-4642-9e70-05a0894c868a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d1ab52e6-ca4b-40ec-b2f3-1c279ef91339_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_44024dfd-311f-4cb7-a823-b8e67da6c9d9_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>iart-20210514_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9d799a3e-0461-448d-85cf-baf8cc48f7a1,g:be4deb8a-a1ff-422e-be34-a925f2b6098d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://integralife.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="iart-20210514.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_479b79ea-c65c-4bd8-88bf-9dd17e5b5716" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_59016371-826b-4f86-9297-5f6a7821ca94" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_479b79ea-c65c-4bd8-88bf-9dd17e5b5716" xlink:to="loc_dei_EntitiesTable_59016371-826b-4f86-9297-5f6a7821ca94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_cb13f09f-0494-4ffc-b84a-5ac8e8e00e65" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_59016371-826b-4f86-9297-5f6a7821ca94" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_cb13f09f-0494-4ffc-b84a-5ac8e8e00e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_b5edde8b-a8cb-4c37-b172-1555acc2fabf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_cb13f09f-0494-4ffc-b84a-5ac8e8e00e65" xlink:to="loc_dei_AddressTypeDomain_b5edde8b-a8cb-4c37-b172-1555acc2fabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_59016371-826b-4f86-9297-5f6a7821ca94" xlink:to="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_171c4d97-cdcb-4768-adc1-2309f27f0ac6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_DocumentType_171c4d97-cdcb-4768-adc1-2309f27f0ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_972aac6e-09f4-4e22-97fb-8cdfc46c2929" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_DocumentPeriodEndDate_972aac6e-09f4-4e22-97fb-8cdfc46c2929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9f9e4be7-6c46-4323-8a3a-6e135fba208a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityRegistrantName_9f9e4be7-6c46-4323-8a3a-6e135fba208a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_91dbdc3c-44d1-4aeb-8c1d-0853046cedfe" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityIncorporationStateCountryCode_91dbdc3c-44d1-4aeb-8c1d-0853046cedfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_6d989612-dcb5-4733-980f-c481e1740922" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityFileNumber_6d989612-dcb5-4733-980f-c481e1740922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6de35d49-12f9-414e-8c6c-0ac4d95338a4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityTaxIdentificationNumber_6de35d49-12f9-414e-8c6c-0ac4d95338a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_8824e021-ef17-4ad9-8ada-40ce4c6236c1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityAddressAddressLine1_8824e021-ef17-4ad9-8ada-40ce4c6236c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b5a7a6ab-5496-4d06-b1d2-4e008f5a6db5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityAddressCityOrTown_b5a7a6ab-5496-4d06-b1d2-4e008f5a6db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b3906ffc-6698-4bd3-a70e-af8a176d9b8a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityAddressStateOrProvince_b3906ffc-6698-4bd3-a70e-af8a176d9b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_edbbc2ee-fffc-41e4-b0e1-11fcb464b696" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityAddressPostalZipCode_edbbc2ee-fffc-41e4-b0e1-11fcb464b696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_83c298fa-e320-47b5-ad2d-2729abc66fc8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_CityAreaCode_83c298fa-e320-47b5-ad2d-2729abc66fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_78d98eb5-ceba-4c51-9283-a383115b34d3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_LocalPhoneNumber_78d98eb5-ceba-4c51-9283-a383115b34d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9e5b1855-efff-47c0-b1ae-b56a8bcdefe7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_WrittenCommunications_9e5b1855-efff-47c0-b1ae-b56a8bcdefe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_fcb0c9d1-8a9d-4d40-b6d0-640f5cfc7d30" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_SolicitingMaterial_fcb0c9d1-8a9d-4d40-b6d0-640f5cfc7d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_e5db3748-8d0b-4cd3-a617-fd6c0fc409ff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_PreCommencementTenderOffer_e5db3748-8d0b-4cd3-a617-fd6c0fc409ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_22660c61-83a4-4d51-9406-e93c214d25be" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_22660c61-83a4-4d51-9406-e93c214d25be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_89b4780a-904d-4358-a17b-92e823456b77" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_Security12bTitle_89b4780a-904d-4358-a17b-92e823456b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_dc8d126d-aeaf-44fe-980c-ec345b74e64e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_TradingSymbol_dc8d126d-aeaf-44fe-980c-ec345b74e64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_219d8934-ff20-4cb7-b973-5a5a95a04aeb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_SecurityExchangeName_219d8934-ff20-4cb7-b973-5a5a95a04aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_7f49f211-703d-47b8-91f0-2db522c2cf3b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityEmergingGrowthCompany_7f49f211-703d-47b8-91f0-2db522c2cf3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4d1ec366-9585-4725-a253-0e80a5650078" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_EntityCentralIndexKey_4d1ec366-9585-4725-a253-0e80a5650078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0e2b9acb-6fcd-447b-a665-f6707f6f925a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_b282825e-2948-4318-9781-96cbfdf40a57" xlink:to="loc_dei_AmendmentFlag_0e2b9acb-6fcd-447b-a665-f6707f6f925a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>iart-20210514_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="iart-20210514.xsd" xlink:type="simple"/>
    <context id="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2021-05-14</startDate>
            <endDate>2021-05-14</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN180L2ZyYWc6ZWE3Mzg4YWVkY2YyNDJjZDkwMWE5ODJmYzk2ZjEzY2QvdGFibGU6OGFlNGU0ODVkMDg1NGUzMmIxOTYxOWNlYWE4NWU4NzMvdGFibGVyYW5nZTo4YWU0ZTQ4NWQwODU0ZTMyYjE5NjE5Y2VhYTg1ZTg3M18yLTEtMS0xLTA_0b454621-dbd0-4df4-80cc-cec592c40ffb">0000917520</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN180L2ZyYWc6ZWE3Mzg4YWVkY2YyNDJjZDkwMWE5ODJmYzk2ZjEzY2QvdGFibGU6OGFlNGU0ODVkMDg1NGUzMmIxOTYxOWNlYWE4NWU4NzMvdGFibGVyYW5nZTo4YWU0ZTQ4NWQwODU0ZTMyYjE5NjE5Y2VhYTg1ZTg3M181LTEtMS0xLTA_5e3c718c-c84f-44fa-88d3-1f0d864f5905">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQ2_806c3915-ca93-4bbb-8df5-4eb7f9a721ed">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8yMzM_8e9c1eb3-5684-49d9-b504-d4031e1ad5c0">2021-05-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQx_3c941315-0729-4e25-8e4d-a83529f062d9">INTEGRA LIFESCIENCES HOLDINGS CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGFibGU6MzQ0YWMwOWU0MjkyNDE5NTkzMmJiODYyM2RjNTQ4NTkvdGFibGVyYW5nZTozNDRhYzA5ZTQyOTI0MTk1OTMyYmI4NjIzZGM1NDg1OV8wLTAtMS0xLTA_b08efcce-df34-4561-b87f-3e3c37b3d8ed">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGFibGU6MzQ0YWMwOWU0MjkyNDE5NTkzMmJiODYyM2RjNTQ4NTkvdGFibGVyYW5nZTozNDRhYzA5ZTQyOTI0MTk1OTMyYmI4NjIzZGM1NDg1OV8wLTEtMS0xLTA_8e61be86-ebc3-4427-b21b-51d4454d6a3a">0-26224</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGFibGU6MzQ0YWMwOWU0MjkyNDE5NTkzMmJiODYyM2RjNTQ4NTkvdGFibGVyYW5nZTozNDRhYzA5ZTQyOTI0MTk1OTMyYmI4NjIzZGM1NDg1OV8wLTItMS0xLTA_096aecec-35dc-4eda-b1be-fc62908ff2a0">51-0317849</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQ3_b5421028-96b0-4e22-bcbc-914b274031fe">1100 Campus Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQy_a7cb77a9-a5ca-48af-9da5-a87851b1e5f7">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzM1_58e3fff8-2d3c-44d6-a196-82c5aa0aaaa9">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzM2_52890413-6f7f-4130-a3b6-afc3168a9eb0">08540</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzM3_bbf16e99-969d-463c-bb27-aeed928134c0">609</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzM4_15ae7b5d-ca07-4dd2-9b67-c70faf743046">275-0500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzM5_de30d3ec-0d52-45b4-abaf-813d660609db">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQw_e80cc92c-a10c-4764-876b-ed00ed36b753">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQ0_4ee38095-8b17-42f1-b390-71188adaa7e7">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQ1_857f681e-49bd-4700-80a9-8947ddffebdc">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGFibGU6MzEwMDA0YTFkMjgwNDhlOGI0NjJlYTM5ZGU4OTgwYzAvdGFibGVyYW5nZTozMTAwMDRhMWQyODA0OGU4YjQ2MmVhMzlkZTg5ODBjMF8xLTAtMS0xLTA_9b1e008e-d359-4e77-9443-2611343267e3">Common Stock, Par Value $.01 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGFibGU6MzEwMDA0YTFkMjgwNDhlOGI0NjJlYTM5ZGU4OTgwYzAvdGFibGVyYW5nZTozMTAwMDRhMWQyODA0OGU4YjQ2MmVhMzlkZTg5ODBjMF8xLTEtMS0xLTA_8e9f9d85-9d2d-44ff-9bb1-faeab8d78e42">IART</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGFibGU6MzEwMDA0YTFkMjgwNDhlOGI0NjJlYTM5ZGU4OTgwYzAvdGFibGVyYW5nZTozMTAwMDRhMWQyODA0OGU4YjQ2MmVhMzlkZTg5ODBjMF8xLTItMS0xLTA_5a899074-f972-43bb-99d8-7e419b299b6a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514"
      id="id3VybDovL2RvY3MudjEvZG9jOjFkYjY5YjhmYWRiNDQ2ZjU4Y2QwNWI2OTk3OGYwOTI3L3NlYzoxZGI2OWI4ZmFkYjQ0NmY1OGNkMDViNjk5NzhmMDkyN18xL2ZyYWc6MjZjMzI0NmU5MzUxNDFjMGJkNWNmNTI3MTdjNDQ0ZWIvdGV4dHJlZ2lvbjoyNmMzMjQ2ZTkzNTE0MWMwYmQ1Y2Y1MjcxN2M0NDRlYl8xNzQz_67f429cf-3e6a-40cd-8995-3445b7248167">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140626489966696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 14, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 14,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTEGRA LIFESCIENCES HOLDINGS CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-26224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0317849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1100 Campus Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">275-0500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $.01 Per Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IART<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000917520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ #H2R4I>*NQS
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M"Q4&L&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ #H2R4@=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  .A+)2
M I8H+^\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    "  .A+)2F5R<(Q &  "<)P  $P              @ '-
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  Z$LE(::I@W100
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M2P$"% ,4    "  .A+)2)!Z;HJT   #X 0  &@              @ &Z$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  .A+)299!Y
MDAD!  #/ P  $P              @ &?$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  #I$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="iart-20210514.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="iart-20210514.htm">iart-20210514.htm</File>
    <File>ex101.htm</File>
    <File>iart-20210514.xsd</File>
    <File>iart-20210514_def.xml</File>
    <File>iart-20210514_lab.xml</File>
    <File>iart-20210514_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "iart-20210514.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "iart-20210514_def.xml"
     ]
    },
    "inline": {
     "local": [
      "iart-20210514.htm"
     ]
    },
    "labelLink": {
     "local": [
      "iart-20210514_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iart-20210514_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "iart-20210514.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 27,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "iart",
   "nsuri": "http://integralife.com/20210514",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20210514.htm",
      "contextRef": "i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://integralife.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20210514.htm",
      "contextRef": "i9b0cc30569904e5ba4f3b166d171a286_D20210514-20210514",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]",
        "terseLabel": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]",
        "terseLabel": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000917520-21-000029-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000917520-21-000029-xbrl.zip
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M5#>;N*LLD_Z]]?1O1:QD21YS^"4[)8L5&5*X->2>!FMN6>H%"&]XZ7NF#0E
M'1T>39Q"OB_&9V?A4=&\\*A>BE%=M7R?]^9<;G,*X_)IO4B:2GW>, 73HZ.)
M.+H&OH"Q+/2^&W/:,[5C&R;%R=O(I8M-&N>\]PS^ZNC9=V"!DP>'V%!B>"6R
MG4I=J9)T5_<QS<-W;.H5#XP. OLK]5%7M;7T,310D=_(^*B1F&FF$;J+8(B\
MD%':0^ TPB_2 G8Z+VHS<O_ %+7(Y27>Y9II<9B3LZ!G,W)UB:P6!TJ;6BN:
M FX\F-&:XLOX6;U.ZFBM:'KP'UW!3T!?*R62Q&I_!/_3<0+#?ZYUEJV:+%HE
M.FM*91BY[SF!08J%VL':LN0:?\O.-5FAQR&"%["Z,],WK5'EE\DE2@4M7AU9
MKZ[610[&W"Z.5F72H#C:+-0__YG1SL?11E>E D.X@K^L5X[=>S+$IBB3+*J;
M<JMK=K_PA&Z:T8>< [M7NL@2LTR<VDJE"H?$C<9H*^X'G\AE([],MENXV,DB
M4\:5>!MLB_#"KP;Q2=YC/KYI6S"\Z]L2G92@6G403^:I15'7Q>;;1^Z19%$5
M65,//_(K0"DOX+%%J8<XS]'MW$F=+;@!OL7_NR[-!+?)I3I8E"KY<)"L8/[?
M)MEULJN^^OTA8^%Y_JM9MH=.(7I>(%9/596Y %<WT/\&0ST:Z!SW#MB=4#^P
MN!6J<#5\I?%:YD5^L(1WJ5J%O%KG5_@SO X5>N>[W)P8$-U5^S+W_4+5UTKE
M'3Y$X=H.@[EI-3#M*VVX58POWV8JP47E<![$N#'J7N*%C>6:9P4S2-!%-ZJ'
ME4A,S1]:AM5N^S*.":=J ]RZ+H$GH"?XYZ;41=,.--@]61$NI&H6E4YU4FIE
M3NW*<*W]C!K/(]MU)&/W;%&CAX5'VP+XE9$L36;>!W_!*V_BE,1H@>L"+ZYP
M%\1#OBR:LJ)]0Q ,_  /VA/L=O?@EM0-1N(ORZ)B<:<O$?B"#QG)!(.CA[Y9
MUO=&S_PT_?_%.LDO*<Q _J@B&Y<M<+?PQ9@U?4/6I\"@EJ IL42,9LR10)W*
M1<6!F[0JBXU_D^:&'5X5-4<.ETW)>E@+$#*38_T'__"]_:&%#2*P#'YH8%@4
ME/2Q?*1L8IP*V4J#<$%4XK8,7J+W58&)_'B6SO'F')W0/W@Z9Q^73%>GRWH>
MZ0U:[, $D#NA4)3+R/HXAT41!6!,4H(G+I%AO+G.X>NUWMH9(I.1&X_T0?Z!
M5?0.F(B93WKP&(.LFR:[3,+06#@K>*P'= !,5YE5 %];D.T@V[XMKF$D/ J@
M3OP!:=A%4X-BEE-(M[/M<>2=;QCDQ7!@"52JE%,B0=8UL/!R%ZT9@^<?-2^$
M,$@FXBQ(3A #2=XF!7:;)"9>C-^52J01BU8OM@S[#,JN)4"2I^8OZVBIT.N(
M$U,=:YS-JP5N1,UBB!Y(0)+!6<![!))4";RI, =+!$7>S'! E@B"2(.IK6'O
MP1B+V?!@G=W=HO:%,6OT?Q/$8F'KX2XG+$>-:(!=Q7TF.;9-2E .DNV:E??9
M*<<*9]_+-2:HJ]A5:(LM$#;78::6^. N^2-.""-KY36B"I%HX,":)$/T8$'N
M-3C7'Y-RN9;[&1-:%+XI\0:#=>5HB2TZ'R5ZGB\;^ FLRO=3S:.E2BI%C E/
M&31&9"&DB1CQ'@&5@&Y4P7%?%P=P .C\]=^SG\ T_Y*<CD B=&ER4#EROB_X
M9O-=W^V(#</.89,-+"2Z1J33%E_)D?X$&0MQFSV3[=TCV%M_K:UM,L_$S&']
M.51"LK1U\%_+UQ>*!M2HE*9X;*WWME\Q?+!F2Z,5 H9Q1\.MS0N/3&0ZK;?+
MRX?>;3PNWC#D_6#UMZH:$#?P+,@01?!C]%XT&9GGXEU&QKBL&S:KZS4!S9#1
M"]F=F:/%:ZRJVI>/@;?8DSLGR<'1T>T$C^<RZ$ZA(MVXMCX &/&CJ,JX113O
M61"#"U"AB1&D+7G3XT>=)0Z$77S<M18Y%^0("I^%O5M"SLY>\G'#R56A4_:7
MU76FZ)?M+<2O6Z^;#@<T+)!@7YM-XK,%*Y%61(A%>0E:RS\3YBH;55[BQ9##
MA:-/K5NI2C)/,TAU9;PH1@,ASZ O<NE#OC)P"U3=$=+B+/.E(HXEORV=($YR
M?JL .AW%?"]F/0ZY$&YH""<&BL_P.U_?<RD+=&7[GT<='R0L;R)I8$2_'?7L
M!K6L5R7KJLRTJ(Q)EQ@P6'_H8B-3.6#[[!/TX@^S<\\X]14HYC#X(E)%!M<:
M2+?W37D%# P>\G!^;C?1'#XW+P2>Y]Q\"!'TW\X*3(O5L2+OJ3F@<U4=)>D&
M.FJ;\D(KPD9]?1%86-%<KH$K*:M'^RZ%,/L#I#\<:.^RR94L/M8;E%*SD([:
M'5" 3XY;2CNIBWTG)!YY?[O#.>&K06Z5E%,#8WG6S/",KM';@\X;5>(0OC8Z
M.)=Y3$HG?1\0>[(I)*1IU''1[CFEX]-4\?B..Q6WV4N/T8D\/M";K:8#0C[Y
MN2B1O?1K.@LCN=)V!+!+/?;0:!MP$T#+Z/Z,,SEZK]V<#^@FK:=F)B,>.N(5
M'V&Y?EQ"5!$G*V/'=SOQB]C# Z],J&> 24Y%7!KG*:O"Z/*]V;PDZ4D6&CI^
M,PT"S$E*D(T45O VU[<B^6WPNRGLGMV\Y5)M:XI-WF[[+,."C:1_ ^6*5BK&
MSE[SWN,,"[5BYHY,+QPI+<@8!I8RS+?W: >MT7Z=)K#7+^-&V"_#VSMU"]8Z
MX.3 7]Y>3@WO\=3]T44ZMGP/DR=;YL"KWH$EFS=X,5(2 4??/'_J)[G>[GAH
MZWL.Z$LP-L"D?PG&MC?N#EF^=\  C$>\C1,/90"&(V1,;0,-_U9@\HGOQ2 C
M0YU3#!8:B?QNH(\#+T#!0R'J.EJI:^M%NBZZ*KC1"] 1:5UXH- 56@PDL5Q4
M>:6,UHRQZJJA\$H<^'N3#PS%$0<N>@%Y_O@CB@^++RV,/#V=+7H#3O=&0M[+
MF^#5(!G+/;AU$0OTF[P$07F=E('J=V\HYE-U*LDT>3F^9%K"@&-X$H&=G('7
MG_(8.3]7@#_1H4,/^)1"N'^877-O#O@^L@1_HT=&70;GSY$GH1-V@F(VXU8K
M]L 9JFGRTDOE(XN9D<=@IT5;3K<Q0<TD6C4UBK/;D6_@\'-Y7O>&,C^-];S4
ME=2D&AEE5 KC\0X\(,GX;2>Z+&.K,(=1&3Q@ ;N 7B=96CP -Y=3/CZ>J?GL
M\=SI3NG4K?C!'+Z144'('T+!LBR:++6< <XSTZH11V12K:/4K)&>O:9?4R&V
M!>)(@5D0(+M@@+F$6IBEH _I9YO&P)&VTZ"N@  U_>FL$PD$R!CT%L]]-'&*
M\A7\D1$1Q12<2\^?*7N('I_<W4-TCP]*ZEB]!3$ZMAI%9(;BO/@>TU6BLUGI
MCSW5-XREC 7-P+X%$0Y'6UEH!PS(Y248.1SF)[D*2,FF:$S:X<YH$2TXVE"1
M!51O4X5P3)0J$R>=5XDN$5+T0=71/Y*L&:.M8B,6B& K-2*Y@/L3F.NR*%),
M:0(Z,$>6M&)2QHTT-5"SC;RB88W %=*015*A"(QX*Q#PY0$Q#*>D"!%>I^)*
ME0<PTL$2KPQE:A U%)ZA" -S'N^,,5 D% 4D@]_#;;Y"XHDVL%MX;=W]F4M2
M'([U2U.@I%UF!165%JX@PZ5D*$\M=JA[C\MD'O8<V[]JS_&[#$$!R/X4!<-H
M6(R(>^ *?)QO%.=&3O&$]-R$8^48^(AJT#XKW+N""^UY):,&+M305:IV,,ZF
M]W3C:-'4[7=SGF&9[<SI$:^#<RHN<UA9\/Y4 0V5WH$3VQ3VMX9U1@O-I6,1
M/)U4'Q (4U(-- M^X!GY: XATIN?%X$>W.+XEN_VGKTE->J<*MM,FQZO',>P
M^/7*SR%FT)>7X)HLBBMEJ=8'41%5>)QCH^IUP0@?X184>T<E0&B5>4I2>2$&
MJ8G<UM3NC69T_QQ\?T&UYAW!@.]K30!O"?VN&F2I-E4P]O+^D3.X[&HN_M=-
M&FT7%FAGC7YZC0!OYK]'I0!O>+F?_@O;6UV(=% ?$0I9V71.P:5[\#QW H3$
M68*$*#G%<F523@-E>CH:,;!&@C9*QFNJ@:TQ,DUWDHL=JK:!S2TIOWE/R06#
M(G3IS:Y$0X_#B%U:B&ETN<$ZEW!O4,FB;TH6;-[-ZIT*$!'+1/AG52K,][WA
MJ+"# JK*2;FS2<L3V0S:#0=TPQVX5 6)?+T$K6DIU29JS[?A$QSI_J;RAU_<
M-G$/.TC?2J_J700K007,I._=_)(<=2XD97F1)*S:UR46HA :+B8OXMH#W2*Z
MG&[)T&&74N=76V98Y-DNR#(+?H,:HL] @5O//O:GLYLIA(A\NFP)LFSQ4?EN
MA/;H-A56E["3:;*K)+O61R&3;#"LEWANLF19L=3ELME4A"&MW)I0!PO$PFSG
MK<!,%--UL2@ ^ZJ7C<$J#HP^.%5RKV_M\?0NG*$DLW]ZTS!G&WA94,H0\#M+
M:@->J?3'X;T)Y=(G;,X7L-]O!_9[_ 7L-T&PWZ<Y@EW51K^(,]5LGH_,)^QB
M "2OXB!%A%BB?*V'BG7'D2D^3=(+V[+8Y4M"WM9J8MW2!P$F[N3XV(\RVXR\
M/D""= 6R M L0[N,]EKZ[O&T8/<'4 Q3+Y+H-W09'_UQIC,8AY**=*4HXPC>
M AR1-%M*7L\/O$]L!8D0SSG0>R!^8,T'PHKP(0_"\O#C94)XFV_%@]JM"F+G
M+-@HQ<^'O@+F !@25>2^(Z*J(RTQ2ML1@Q T0&YN P,N=B=XU-09"Y_+&*A)
M5PX,PS@Y4S37-UK(U>WZ5%'&*99[E,"XC1L@EL8AXNPCY&^_-T=Z_URUO36O
MQ^"T]:D+SHX+J9#K-8[@J0_,D#"54W%,G3P")A!9FN"B0F@FFN4LH> 1@]$T
M;,UG(T$IYV>'SR,FV'M#?Y_&4EI^C,_-5X*^2;X>A<=J.SQ1'@GZ% C59@[3
MDDRH,$_] -LM,\9VC'?$5 _"J+UNINB9JS%"8=W:3I_P]^,O!5:6ZM<53AX0
M7= ^C(PN+NEL4M3G>OI8P5&!0:DWF"0M1T>YT\URB09J7^TZ6YFTM[LEL@^O
MN>5%\#:>ED5)\*M8'\'V 92&QG%_*C9+.C+./]"<+:'#-+I];)PN?0@2EUO4
M"RU7RKXC;FT#3XSJ?GMU4MKA,%L]%XO!4G2B$^JTY7)"Z^TNFQ:[JAP]F80#
MIJ#UC;<L0OOY=5%FZ36VD2VVDL<'8Y7JDN%?_H>$3"EW[F3<EUX+DZ"*3.RV
MI@'3!&?IK<=+Z:IB FA7_,_+LFBV\-]5DR_M3BB_1:MYV>S%;[\E"Z"3U,X"
M#X@_H8BM63M_]'#;M9UB92&L=IPC<FGJ?6N&VZV]2+;)$JOB-#60T3\_H?C+
M_=N-X<YJ+S#38@5<<>I;,-Q"[451U2@XL6PDM7N:^E;L:YDF.!=LPIU7:O);
M,=PE[05,MMA0!+7FNO=3WXOA;FAV+[#L0;62,EN>4 ?!>UVOI[Y!P[W07H(=
M5E:4A#GM+?AF< O.DC*G<@!26<ET$P<%/?F(NF.JO-P;!!PD&ZSG]# $\-&C
M8;TLQ?FB%_?+#N[;P6'-UI(>]1Y$;\CD-V-8O>V2T\/9E6$U]VQ9H%-\*8YN
MU'#"3V"Q*IW\!@TKP=9K[(OXR>_'L"9\EE_ILB!W:9)%:Y5D"!S$BDO)2DU?
MSA\-*\:O=)[DU#P$MX,S39;)%KVM!V6B*?',JXH\>1/B:%AO?E7"A5H^% O[
M:%@__@MU@D) @R)@[DK?5)[^P< R3[[ ,G\/6.8]O#[#ME5P?2B->.J\Y'C8
M7CK'&M4;OS^HE*T6&!5&=/02Q!/P&2P",_V]&K:,SG,,FU64;K(T3AS,L)G\
MG@P;2.?4Q[(H=P\G%C)L%TDQ$"X4D/C546R=@LGOSK!1)+OS((SGXV%;Z$=J
MHL.)M'YK&\UE01^"I7@\; ^]5C6E?6XP$127.?F]&#9XO+W 6+UQ1>7VX\GO
MS; -](:Q%V =/QB+\'A8I76[8?R44]^,Q\,JK=L,MHT?""-Y/*RXMG=D\ELQ
MK*^^+=5!G7Q\( ST\;"N2O4.*9KQ_B$H9(^']=*W=">D..X#";X_'M9/@^V8
M_#X,:Z)_PX2P![ #P_KG.[4L&TUR XV53:*I+ _)$>K>FJLLGO+6#*N?[ZC,
M'/D]%D6ZBVQSN!5[T#:80I880"27;X5?8,66R1/4L)KZ3E4*6S 3.:7J2F7%
MEE(HDN5:JP>"%SP9UES?*72B4=%$:EPZ^:T85EG=5D@T=/)[,:RSNKU0OS0/
M0"2=#&NM;BMT?J6J6NK:$<(+?22V:,X28<@8OW@@U#.LWKHM0\?1 V$LP^JM
MVXX'$?H[&59P36_(AV'QG.S3<WDC9CI?9@U5T+VD&'$I7TBL6/Z<3WZKAO7>
M]U1U^X%0S+ BR]OP,/R*3X;U5=J& U/?X)*S?">^&\,J*R?:=H._D]^28<WU
M@EI/>9VZ,?\'Q._DMV18@_VI*#]PV,I33-$>GO!N#"NG_ZN2\@"[4F$4[PN(
M4?;KGH$8?VWQT#$B'L=<S F+1W1++DC7)ZEV+H7BA=2I\BQG_%<$\$M**:J6
M4Y7M4@DT7QN(&Q4W<O]N/<8=!ZDV@$#6J?2 *?M=F(X(6Z\.!>R<7B;<E;GD
MO[ 2QK2+H&3)*,JEM;I"W;H#<?1*K^IU=,JMX$A,O5-4B3.-CA\]>DP-$^N=
M5\.+2X1B#PPX?CA[>!KK6&E)L:LBBL<3I4J#.2FGC25,L,H*_/?>$,7]*[GV
MMM1P^?"0QE!G[=/)LFC*3Z1+0W54\B>IHZ4JN=<$?LYM*&B8_VZR'<N(HZ<Q
M#'K\Z M9_FYD2;'6U0[UX@M7(WUD))I$K2YY26\5?M.:UW8=<L6E;-%\+"SV
M(FE8MLYTZY=^"<MV%7VO$0QUF[*]Z'H;PL0W=(3A&U#<W,WEWM#^I\GI@3))
M(Q+;2I.>E9@>0;;*U,XO(V4FW:I/-M/4QV8>][=\9N([.3Z9K>9A/6[IX6+:
M2H/ZE]>_Y?O40^HR+1**+M[9:H5[ 8+II93>&A&MN985N6UKHBMJ@;+VY"1*
MW=);D^FG!)(VND9)&S8_^[X WO, CKC4R]J4X1[9P8:U,*D>8+L2IBN)G!<<
M1,4FBUX'\&MX%,4+'3VNE>O?E7X3S6X]Q?X:F(\G3@Y>F^W1]P%W[;\?/Z#V
MWR8I:U0G4TDAZ14AR3!2S17I R$[]8,9Z# ^LJ,:*$+O^&E0@MY5&<9'J<]Z
M3,FDF,)2E%X%\02/?F%L#5.[?L9-J[!A&1>HW<-RY['_K49)7F3&7@!-CKJ
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MNIX$@&,/+I6BOX!?[CDC; T9'T@5@D<=R-1=8A!YY]X#P#N0@?I1CIL&(-:
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MKN<BYSM3Y*#G1C-[,?>TDFX>:"Y*LOEUPB-:42SCA5I]T+8++1,W(_:SP)M
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MR!O(*T1*:MK5A_.&+7F6MC'V/=A,J& XHM;?.V/,&=83<C;Z"5!+ P04
M"  .A+)29B88%/L'   O.0  %0   &EA<G0M,C R,3 U,31?9&5F+GAM;-U;
M;6_;.!+^WE_A\WX]QB1%4F309-%+VT.PW6W19-'%?C'X,G2$RE(@*4WR[V_D
MQ&D2*^FMQ=N#@P*I+-.<9^89#6>&U.N?KY;EY!LT;5%7!U.V1Z<3J'P=BFIQ
M,/W]]#W1TY\/7[UZ_0]"_OC7YP^3M[6_6$+538X:L!V$R671G4V^!&B_3F)3
M+R=?ZN9K\<T2<KCZT5%]?MT4B[-NPBEGC[]M]DW(C;$9$"H4(T+H0+3TD3@;
MM?="Q]RR?R[V'8@ 3EMB68Q$< [$02:(-5Q&[A0U^,-^TK*HON[W?YQM88+*
M5>WJX\'TK.O.]V>SR\O+O2O7E'MULYAQ2K/9>O3T=OC5QOC+;#6:&6-FJV_O
MAK;%T$"<ELW^^/7#B3^#I25%U7:V\M\%H/C0W?WP/AHYN_D2A[;%?KOZ_8?:
MVVY%SP]5F#PYHO]$UL-(?XLP3C*V=]6&Z>&KR>3&<K;Q35W"9XB3V\O?/Q]O
M(BVJ;A:*Y>QVS,R6)2)>S=!=G\/!M"V6YR6L[YTU$)]$OU:Y!R5[.#_UL\U&
M8SI#((V_<$#P+E2]@R?$.#3[>,QW<Y$ T5Z474+$FW,GQ5LO;9'2P!M3)T"[
MFH@L8>F@20GUP;SW<*Y!/D:(P&#1V+*(L.?KY6R%;AU9;17>55W171]7L6Z6
MJT?_QV +V_2(.*.2B16J9^>[!Q*]H:B*_NX'_'@[:8\H%5RXZJ *$*:3(B!0
M1G4P,GJ,_%%P+8V0&.JMTSQ3>:;8_-F9>]QKY&7M'P@J^T!9WS%;6@?EZNX\
M0#'?F O5A>,.ENW<<8W_),9%(S01&=/$Y)H1H[R+(0IJ9;[I&^W:UUKP>XOZ
MVPREH(,PTU^0_H)0=AMB?WH>P0T?V^FU-M<ICIVSG'D13$Y\\(Z(7&EB@V>$
M9]1$GD=JO4J@R7V9#[%_]Z8WS5J+V^=ORP>TSRJ2L]C5"0QXPPZ"GT[J)D!S
M,*4IB/P$35&CZX>WF&#-3<XMRL0$R41!!'".6D5'M _1"^6YX28AHP^$OQAJ
MMS?I)L=L#,<W.GZ&1=%VC:VZW^P2\40#PD%.%$I'[7A&M,TL4< R&9WE5-MD
MX>>A[)UG>+1!-PGFXPD^QA*J.:^;E9(G'3K=47U1=<WU41T0'@LN^,QCN1.P
MYK'0NQX+A&J981GD(<2!5&3KY>89*"^$_G3FWO2&;+PWO"]*^.VBM\M<!:.-
MPLH+5Q>)RTN6$:-I)%CI,F"YH(;S9-1_E_M">-[2D)NDBO&DGMJKXX!+2Q&+
MF_+\#AAD,@B#Y74T1# !Z&W*$TP<,*^06::M2,;P$R!>"-TI3+S)O1S/_9L0
M&FC;V_]Z==E<:RX ZR\"D>4898+!-2=8(J@'X146-YXEXWT P OA?*QI-_E6
MR?@^PLN/S6E]6<V=M+E5UA$I#&88@2KB6."83%*JH[0J.)F:[>_B7Q;76YIU
MD^D\&=.K'.)C\ZFIOQ65A[G+#%4Q>J*403U=R(C-*1 ;M64YKD4N888^C.%E
M<3[&P)O$ZV3$?ZK;SI9_%N>KS!&"<YX#D-A#$PP$<10882QZ)Y1PRJ3HICR-
MX&61OKUQ-RDW8RCO(\Z;!NP*A\ZPX-?1$L@XQ4P2TTD;>" \Y\8ZKU3T.@')
M]V7N/*U;&W"@G3*J9];OC96?SNIJ71?D&@L#0 @>'&8(7J(R7&,TR73&F'29
M"%D"-A_+W7E&1QER@-517;(O3=%U4!W5R^5%=9O[MW,#TC$M)::!_1YP[BDF
M!Q:(D\IJY]'HD*)+/RA\Y_D=;](!DD=URD[JLO!HQ&KQ*^8"36'+.09^ZDU@
MF-Z;@.F?0#@J4*($C=)'GX>,)F!X4_+.TSO2F /<CNI[?6J@]S3 U&ZUL]+O
M_S4?8\2X C*X+$?E=* .XTJ?Z2DLZV)0GD8OJ(DQ <=/(]AYKA,9=X#S46VQ
M1[".V_8"FOO@.%>*>H4.F5F!#MFO* (K/#"80# 1N'0IVMX_PO'2^!]GZ $O
M&-4@.P%_@4O-->/NM.A*S Z-$[FFEA@J, QE4A.LZ!PF$Z!Y)J1R>8I5^['<
MG6=YE"$'6!W5!CMM;'\B\.1ZZ>IR'KP.C*M +%C,&D2$OO?N"7B$X7(!2J1X
MD!\(W7D^MS?A )FC.EUKSWIWY<]LM8#5EBEG)FB3":S&^R+.NYPXDV=$6FF-
MM+3?-DOXF-Z7O?/4CC;H ,,)6EKOEM LT.7^W=27W1DN&>>VNI[G49C(&2,Y
MS4)?K:.2+%+"@Y.<>^YCEH+H9R#L/-^IS#M ^ZBVU@VN(\P)&EL>8SYP]0M<
MST5@&%64(D;J?J>42V*YS @%7$RDDI3F*?I;@\)?"-5C3#IPOF14Q^L-YGRA
MS_O>EW8QI\"=L=X1%3VZ&_H;)OQ*DJARFD<5#9<I-B8>"-UY4K<WX0"9XX^#
M%=">6H<9GC24J2S'O)TKK-ZB1@?C)B<R*IMKSKPUR8X.K(4F)//>2P!_SW.Y
ME>&&#O1-;DYT[_NR;B$<3+OF K[?K*L.KKIWY:K:.IBVL.@ODFTYP7JSNS]_
M^N:J:.?>L2QBJ4ZH,%B_]=LC3@N+J8/7H(%24,DWES=0)'2,9][$&'"4[5A]
M:L]IG'43G_Z\!^7M*O+]5V#FC]X%&1/''P-(&<N?>G=E*!BD8:=.;=K_.=].
M0@B@<8G1_?%RGV%5P').F)2(R_-H78KNY]_$\X-W?OY/-/\5BSY)[^O9([O@
M"O7U\-7M[?Y/_]K<X:O_ %!+ P04    "  .A+)2E9%8,N8+   Q;@  %0
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M<+OO-$%\-:ULZDD>:2J9R&[\\M/KS;X[>9:@R\WR_B/<<7/9[--8#L-E#TV
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MNU*#74O5#1/Q.55]#\U!NUR>-S>+LFYN0#JFI<0<.[]B57J*V9,%XJ2RVOF
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M+VX.Y(_\X\K7+_X/4$L! A0#%     @ #H2R4I"/%9B[3@  LBX"  D
M         ( !     &5X,3 Q+FAT;5!+ 0(4 Q0    (  Z$LE*[Q05*@1L
M /;G   1              "  >).  !I87)T+3(P,C$P-3$T+FAT;5!+ 0(4
M Q0    (  Z$LE+DGWN=C0(  +T(   1              "  9)J  !I87)T
M+3(P,C$P-3$T+GAS9%!+ 0(4 Q0    (  Z$LE)F)A@4^P<  "\Y   5
M          "  4YM  !I87)T+3(P,C$P-3$T7V1E9BYX;6Q02P$"% ,4
M"  .A+)2E9%8,N8+   Q;@  %0              @ %\=0  :6%R="TR,#(Q
M,#4Q-%]L86(N>&UL4$L! A0#%     @ #H2R4MESJ)B-!P  *CL  !4
M         ( !E8$  &EA<G0M,C R,3 U,31?<')E+GAM;%!+!08     !@ &
+ 'X!  !5B0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
